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Edwardsiella ictaluri is the causative agent of enteric septicemia of catfish (ESC),
which is the most economically important disease of farm-raised channel catfish. E.
ictaluri is considered a facultative intracellular pathogen like other well-known species in
the Enterobacteriaceae, and it is capable of surviving inside channel catfish neutrophils
and macrophages. Its ability to survive inside neutrophils and macrophages has made the
development of an effective vaccine against ESC particularly challenging. The goal is to
develop a safe, efficacious live attenuated ESC vaccine that is practical and economically
beneficial to catfish producers.
In this study, single and combination of mutations in genes encoding TCA cycle
enzyme and C-1 metabolism proteins were constructed using in-frame mutagenesis. The
virulence, vaccine efficacy, and tissue persistence of the constructed single and
combination mutants were determined in channel catfish. The constructed mutants
EideltasdhC, Eideltamdh, EideltafrdA, EideltaglyA, EideltasdhCdeltamdh,
EideltasdhCdeltafrdA, and EideltasdhCdeltagcvP were significantly attenuated and
showed 100% protection against E. ictaluri 93-146 infection in juvenile channel catfish.

However, when tested in 15-d old catfish fry, mutant EideltasdhCdeltagcvP and
EideltafrdA were found to provide good protection (99% and 60%, respectively) against
E. ictaluri 93-146 infection. The tissue persistence study indicated higher tissue
concentration in mutants EideltasdhCdeltagcvP and EideltafrdA relative to the tissue
concentration in EideltasdhC and EideltasdhCdeltafrdA mutants.
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CHAPTER I
INTRODUCTION

Aquaculture industry in the United States
With over a 1.4 billion dollars of sale values (Table 1.1), the aquaculture industry
is an important component of the United States (U.S.) economy (USDA, 2007). U.S.
aquaculture production comprises the production of food fish, baitfish, crustaceans,
mollusks, ornamental fish, sports/game fish, and other aquaculture products such as
reptiles and turtles. The major food fish species grown in the U.S. are catfish, trout,
salmon, tilapia, hybrid striped bass, sturgeon, walleye, and yellow perch. Among these
food fish, the channel catfish (Ictalurus punctatus) industry is the largest, accounting for
over 50% ($455 million) of all food fish sales ($854 million) (USDA, 2007). Mississippi,
Alabama, Arkansas, and Louisiana are the main catfish producing states with over 286,
132, 95, and 14 million pounds of catfish sales per year (USDA, 2007).
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Table 1.1

Total sale value of aquaculture industry in the US, 2007 (USDA, 2007).

Aquaculture type
Catfish
Trout
Other food fish
Baitfish
Crustacean
Mollusks
Ornamental fish
Sports/game fish
Other aquaculture products
Total

Sale value
(million dollars)
455.4
210.6
187.7
40.3
50.9
243.0
61.0
80.6
85.8
1415.3

Channel catfish commercial production process
Channel catfish spawn during the late spring when water temperatures reach
approximately 24°C. During spawning season, eggs are collected from nesting containers
in broodstock ponds and transferred to the hatchery, where they hatch in 5-8 days,
depending on water temperature. Fry at this stage are called sac-fry, and they feed on
yolk for the first 3-5 days. After that time, they swim to the surface seeking food and are
called swim-up fry. After feeding them for 2-7 days, fry are then stocked into nursery
ponds. In nursery ponds, fry are grown to fingerling stage (3-8 inches) for 5-10 months,
and then they are harvested and stocked into grow-out ponds and grown until they weigh
1.2 to 2.5 pounds (MSU Extension Service, 2010).
Disease affecting channel catfish industry
Channel catfish are susceptible to a wide variety of diseases including viruses,
bacteria, fungi, helminths, and parasitic copepods. Some of the most important disease
organisms prevalent in catfish are discussed below.
2

Catfish virus disease (CCVD)
Channel Catfish Virus Disease (CCVD) is caused by Ictalurid herpesvirus
(Camus, 2004). Clinical signs of CCVD include erratic swimming, exopthalmia,
distended abdomen, and haemorrhage at the fin bases (Camus, 2004). Histopathological
examination reveals necrosis and extensive haemorrhage (Fig. 1.1) in vital organs,
especially in the liver, kidney, and gastrointestinal tract (Camus, 2004). Epizootics
usually involve high mortality and occur sporadically on commercial fish farms in the
southern U.S. during the summer months (Gray et al., 1999). There is no treatment
available for CCVD or other viral infections in catfish. Management practice is the best
way of limiting the frequency and severity of CCVD outbreaks in cultured catfish
(Camus, 2004).

Figure 1.1

Clinical signs associated with channel catfish virus (Ictalurid herpesvirus)
disease.

Source: http://ag.ansc.purdue.edu/courses/aq448/images/ccvd.jpg.
Columnaris disease
Columnaris is one of the oldest known diseases of warm water fish, first described
in 1922 by Herbert Spencer Davis (Durborow et al. 1998). Historically, the causative
bacterium of this disease has been named Bacillus columnaris, Flexibacter columnaris,
3

Cytophaga columnaris, and most recently Flavobacterium columnare (Durborow et al.,
1998). Fish with columnaris desease usually have brown to yellowish-brown lesions on
their gills, skin, and/or fins (Fig. 1.2). At first, bacteria attach to the gill surface, grow in
spreading patches, and eventually cover individual gill filaments, which results in cell
death (Durborow et al., 1998). Other syndromes associated with columnaris include white
spots on mouth or edges of scales and fins, cottony growth around mouth, disintegrated
fin edges, and saddleback lesion near the dorsal fin (Durborow et al., 1998). Treatment
for external columnaris infection includes treating the culture water with therapeutic
chemicals accepted for use on food fish. Potassium permanganate (KMnO4) is a
commonly used therapy. Antibiotic treatment for external and internal columnaris
infection includes Terramycin® (oxytetracyline HCl) medicated feed (Durborow et al.,
1998).

Figure 1.2
Characteristic lessions caused by Flavobacterium columnare.Source:
http://microgen.ouhsc.edu/f_columnare/f_columnare_home.htm.
Proliferative gill disease (Hamburger gill disease)
Proliferative gill disease (PGD), also called hamburger gill disease, is one of the
common diseases in farm-raised channel catfish. It is capable of killing a few dozen fish
4

over several days, or up to 100 percent of the fish in less than three days (Mitchelle et al.,
1998). However, the disease rarely reoccurs in the same pond (Mitchelle et al., 1998).
The causative agent of proliferative gill disease is the myxosporean myxozoan parasite
Henneguya ictaluri (Pote et al., 2003). Early clinical signs of this infection include
anorexia and listlessness; infected fish often try to compensate for damage sustained to
their respiratory apparatus by moving toward regions where dissolved oxygen
concentration is higher (aeration devices or in shallow areas of the pond) (Pote et al.
2003). Gross lesions are characterized by swelling and fragility of the gills as well as by a
mottled red and white appearance (Fig. 1.3), which led to the condition’s nickname
“hamburger gill disease” (Whitaker et al., 2001). There are no scientifically validated
treatments or preventive methods for proliferative gill disease. However, increasing
aeration to increase dissolved oxygen concentrations can reduce mortalities during a
disease outbreak (Mitchelle et al., 1998).

Figure 1.3

Gill lesions caused by proliferative gill disease (PGD).

Photo courtesy of Dr. Bob Durborow. Source:
https://srac.tamu.edu/index.cfm/event/getFactSheet/whichfactsheet/122/.
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Enteric septicemia of catfish (ESC)
The causative agent of enteric septicemia of catfish (ESC) is the gram negative
bacterium Edwardsiella ictaluri, which is one of the most important diseases of farmraised channel catfish (Hawke et al., 1979). Catfish affected with ESC often are seen
swimming in tight circles or chasing their tails. This head-chasing- tail, whirling behavior
is due to the presence of the Edwardsiella ictaluri in the brain. ESC is characterized by
external haemorrhages (Fig. 1.4) on the ventral surface and around the mouth, white focal
lesions on dorsal surface and sides, and occasionally a grey lesion on top of the head that
can erode to an open lesion (Hawke et al. 1998; Plumb 1998). Oxytetracycline,
sulfadimethoxine/ormetoprim, and florfenicol are the only treatments currently approved
in the U.S. for treatment of ESC (McGinnis et al., 2003), and are delivered orally as
medicated feed.

Figure 1.4

Characteristic lesions of ESC caused by Edwardsiella ictaluri.

Photo courtesy of Drs. A. Karsi, M. Lawrence and L.A. Hanson.
This study focuses on developing live attenuated vaccine against ESC. Further
details on the causative agent of ESC, Edwardsiella ictaluri, including clinical signs,
treatment, pathogenesis, and vaccination, are presented in the following section.
6

Edwardsiella ictaluri
The causative agent of ESC, Edwardsiella ictaluri, belongs to the
Enterobacteriaceae family and is in the same genus as Edwardsiella tarda, a pathogen of
humans and fish, and Edwardsiella hoshinae, an inhabitant of birds and lizards (Hawke,
1979). E. ictaluri is a short, pleomorphic rod, measuring 0.75 × 1.5-2.5 µm (Fig. 1.5); it
is weakly motile at 25-30°C, but not at higher temperatures (Hawke et al., 1998). Optimal
growth temperature is 25°C (range: 15-35°C), with absence of growth at 37°C (Hawke et
al., 1998). Even at optimal temperature, E. ictaluri is a slow-growing bacterium,
requiring 48 hours for typical growth to occur. Biochemically E. ictaluri is lactose
negative, catalase-positive, cytochrome oxidase-negative, glucose fermentative, and
reduces nitrate to nitrite (Hawke, 1979; Shotts et al., 1989).

Figure 1.5

Transmission electron micrograph (left) and scanning electron micrograph
(right) of Edwardsiella ictaluri strain 93-146.

Source: http://microgen.ouhsc.edu/e_ictal/e_ictal_home.htm.
Clinical signs and treatment
ESC affects all sizes and ages of catfish during the late spring and the fall when
water temperature is between 22-28oC. There are two forms of ESC: an acute form and a
7

chronic form. The acute form is characterized by enteritis and septicemia of channel
catfish, whereas the chronic form is characterized by meningoencephalitis (MacMillan,
1985; Newton et al., 1989; Shotts et al., 1986). In the acute form, farmers experience
economic losses due to rapid mortalities (Shotts et al., 1986). In the chronic form, farmers
experience economic losses due to decreased production, with fish manifesting signs
three to four weeks after an acute outbreak (Newton et al., 1989).
Sulfadimethoxine/ormetoprim and florfenicol are the only treatments currently
approved in the U.S. for the treatment of ESC (McGinnis et al., 2003), and both are
delivered orally as medicated feed. However, one of the earliest clinical signs associated
with ESC is anorexia; therefore, these antibiotics are only effective in limiting the spread
of an outbreak and not in treating the disease. The first “ESC window” is when pond
temperatures drop into the 22-28°C and fry are stocked into nursery ponds in the fall.
Producers experience greatest losses due to ESC during this period. Therefore,
vaccination strategies for ESC are usually aimed at protecting catfish fingerlings during
the fall.
Vaccination against ESC
The three routes of vaccine delivery available to catfish producers are injection,
bath immersion, and oral (in feed). Injection is not feasible because the individual fish
value is not high enough to justify labor costs. Bath immersion is economically feasible,
but because of current production practices, it can only be done with fry prior to stocking
into nursery ponds. Thus, there is only a maximum of 2 weeks post-hatch available for
vaccinating fry by immersion. Once fish are stocked into nursery and grow-out ponds,
oral delivery is the only route available.
8

Live attenuated vaccines can provide effective protection against certain diseases
because they can express protective antigens without causing infection in the host (Lan et
al., 2007). Identification of genes that are essential for bacterial virulence can provide
new gene targets for attenuation by introducing defined non-reverting mutations into
chosen target genes. A chondroitinase mutant (Cooper et al., 1996) and auxotrophic
mutants (aroA and purA) (Lawrence, 1997; Thune et al., 1999) are live attenuated
vaccine candidates that have been developed for E. ictaluri. Although the aro mutant is
attenuated and highly immunogenic, it is not in commercial production because studies
have indicated that they give rise to silent bacteraemia in catfish (Lan et al., 2007). The
currently available commercial live attenuated vaccine (RE-33, marketed as AquavacESC by Schering-Plough) was developed by selecting for rifampin resistance. However,
the genetic basis for attenuation is undefined (Klesius & Shoemaker, 1997), although it is
known that RE-33 expresses shortened LPS O side chains (Arias et al., 2003). Despite
availability of the commercial vaccine RE-33, there has been no reduction in the
prevalence of ESC in the industry (USDA, 2003; Anonymous 2006). Thus, there is need
for new attenuating mutations that will yield a vaccine that retains immunogenicity and
results in a safe, efficacious vaccine for ESC.
Pathogenesis of ESC
Potential portals of entry for E. ictaluri in catfish include the olfactory sac
(Miyazaki & Plumb, 1985; Morrison & Plumb, 1994; Shotts et al., 1986), intestine
(Baldwin & Newton, 1993; Newton et al., 1989; Shotts et al., 1986), and gills (Lawrence,
1997; Nusbaum & Morrison, 1996). The mechanism of adherence is yet to be worked
out, although genes encoding fimbriae and a type III secretion system have been
9

identified (Thune et al., 2007). It is known that E. ictaluri is capable of rapid penetration
of host mucosal membranes; following infection by gastric incubation, it was detected in
posterior kidneys 15 minutes post-infection (Baldwin & Newton, 1993). Following
immersion exposure, we have found that the organism can be detected 30 minutes postinfection (Lawrence & Banes, 2005). E. ictaluri is resistant to normal catfish serum
(Karsi et al., 2006; Ourth and Bachinski, 1987), which is at least partially mediated by the
O polysaccharide portion of LPS (Lawrence et al., 2003).
E. ictaluri is a facultative intracellular pathogen with the ability to survive inside
professional phagocytic cells. Phagocytosed E. ictaluri have been observed in several
pathology studies (Baldwin & Newton, 1993; Miyazaki & Plumb, 1985; Morrison &
Plumb, 1994; Shotts et al., 1986). In vitro studies have shown that E. ictaluri is capable
not only of surviving in catfish macrophages but also multiplying within spacious
vacuoles (Booth et al., 2006). Although E. ictaluri is effectively phagocytosed by catfish
neutrophils, it is only killed by neutrophils to a limited extent (Ainsworth & Dexiang,
1990; Waterstrat et al., 1991). Previous studies conducted at our lab identified several
genes necessary for survival in neutrophils (Karsi et al. 2009), including genes encoding
TCA cycle enzymes, glycine cleavage system, a sigmaE regulator, the SoxS oxidative
response system, and a plasmid-encoded type III secretion system (TTSS) effector. A
TTSS mutant was found to retain its ability to invade catfish cell lines and macrophages,
but it was defective in intracellular replication (Thune et al., 2007). It has been suggested
that E. ictaluri’s ability to survive in phagocytes may be responsible for development of a
carrier state for ESC (Klesius, 1992) and that it could be a mechanism for dissemination
(Miyazaki & Plumb, 1985; Shotts et al., 1986).
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Description of TCA cycle and C-1 metabolism pathway enzymes selected for
mutagenesis in E. ictaluri
Earlier studies conducted by Karsi et al. (2006) indicated that mutant EiAKMut5,
which has an insertion in sdhC, and mutants EiAKMut2 and EioAKMut8, both of which
have mutations in gcvP, were found to be completely avirulent in juvenile catfish by
immersion exposure and were very effective in generating protective immunity. The
same study also showed good vaccine potential of EiAKMut12, which has an insertion in
mdh; it caused a low level of mortalities (4.45%) in juvenile catfish by immersion, but it
generated 98.96%protection.
Thus, based on earlier findings, five genes (sdhC, glyA, gcvP, frdA, and mdh)
were selected for mutagenesis. Three of these genes encode TCA cycle enzymes (sdhC,
frdA, and mdh) and two encode single carbon metabolism proteins (glyA and gcvP).
Gene frdA was chosen for mutation because it encodes fumarate reductase, which
catalyzes the same reaction as succinate dehydrogenase but in the opposite direction.
Thus, the two proteins can functionally replace each other. The following section
describes the roles of these selected genes in virulence.
The sdhC gene encodes one of four subunits of the succinate dehydrogenase
complex. It is one of the two subunits that anchors the complex in the cytoplasmic
membrane (Nakamura et al., 1996). Succinate dehydrogenase is part of the aerobic
respiratory chain and the TCA cycle, oxidizing succinate to fumarate while reducing
ubiquinone to ubiquinol. It is closely related to fumarate reductase, which catalyzes the
reverse reaction. Succinate dehydrogenase and fumarate reductase can replace each other
(Guest, 1981; Maklashina et al., 1998). In E. coli sdhC mutants, succinate
dehydrogenase activity is located in the cytoplasm, and it utilizes artificial electron
11

acceptors; in contrast, wild-type E. coli has membrane-associated succinate
dehydrogenase activity with ubiquinone as the electron acceptor (Nakamura et al., 1996).
In E. ictaluri, sdhC is the first gene in a polycistronic operon that encodes the four
components of succinate dehydrogenase; therefore, it is possible that the mutation in
sdhC has a polar effect on expression of downstream genes. E. ictaluri also has genes
encoding the fumarate reductase complex in its genome. In E. coli, fumarate reductase is
expressed under anaerobic conditions with glucose as a carbon source. Although SdhC
has similar function, hydrophobicity, and protein size compared to the membrane-binding
subunit from fumarate reductase (FrdC), SdhC and FrdC do not share significant
sequence identity (Wood et al., 1984).
In E. coli and Salmonella, succinate dehydrogenase is known to contribute to
pathogenicity. The organic acids formate and succinate have a protective effect in
stationary phase cells against killing effects of antimicrobial peptide
(bactericidal/permeability increasing protein), which appears to disrupt the bacterial
respiratory chain (Barker et al., 2000). The maintenance of protective levels of formate
and succinate requires the activity of formate dehydrogenase and succinate
dehydrogenase, respectively. In Helicobacter pylori, fumarate reductase was found to be
essential for colonization of mouse gastric mucosa (Ge et al., 2000a).
Recently, it was shown that a full TCA cycle is required for Salmonella enterica
virulence, and a sdhDCA mutant is attenuated in an oral mouse infection model (Tchawa
Yimga et al., 2006). The sdhCDA Salmonella mutant is not fully avirulent, but when it is
combined with a fumarate reductase (frdABCD) mutation, the resulting double mutant is
fully avirulent and effective as a live attenuated vaccine (Mercado-Lubo et al., 2008).
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This study concluded that fumarate reductase was able to partially restore succinate
dehydrogenase function in the sdhCDA mutant, but when both sdhCDA and frdABCD
were mutated, succinate dehydrogenase function was completely eliminated, resulting in
full avirulence. Interestingly, the Salmonella sdhCDA-frdABCD mutant replicated
normally in Peyer’s patches, but it was defective in growth in spleen and liver (MercadoLubo et al., 2008). This defect in systemic infection was presumably due to inhibition of
ability to replicate in phagocytes, which corroborates findings of Karsi et al. (2006) with
the E. ictaluri sdhC mutant.
Malate dehydrogenase (MDH) catalyzes the conversion of oxaloacetate and
malate utilizing the NAD/NADH coenzyme system. The active site of malate
dehydrogenase is a hydrophobic cavity within the protein complex that has specific
binding sites for the substrate and its coenzyme, NAD+. In its active state, MDH
undergoes a conformational change that encloses the substrate to minimize solvent
exposure and to position key residues in closer proximity to the substrate (Goward and
Nicholls, 1994). In Salmonella, a mdh mutant was avirulent in the mouse oral challenge
model (Tchawa Yimga et al., 2006).
The gcvP gene encodes a protein that is part of the glycine cleavage system. The
glycine cleavage system is a loosely associated four subunit enzyme complex that
catalyzes the reversible oxidation of glycine to form 5, 10-methylenetetrahydrofolate,
which serves as a one carbon donor. It is one of two sources of 1C units; serine
hydroxymethyltransferase is the other (and is considered the more important source).
Expression of the glycine cleavage enzyme system is induced by glycine (Meedel and
Pizer, 1974; Stauffer et al., 1994, and gcv mutants are unable to use glycine as a 1C
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source and excrete glycine (Plamann et al., 1983). The glycine cleavage system is also
part of the formyltetrahydrofolate biosynthesis system. GcvP is a 104-kDa protein that
catalyzes the decarboxylation of glycine. In E. ictaluri, gcvP is the third gene in a three
gene operon; it is located downstream of gcvH and gcvT, which encode subunits of the
glycine cleavage system. E. ictaluri also has a gene that encodes serine
hydroxymethyltransferase, which plays an important role in cellular one-carbon pathways
by catalyzing the reversible, simultaneous conversions of L-serine to glycine (retro-aldol
cleavage) and tetrahydrofolate to 5, 10-methylenetetrahydrofolate (hydrolysis) (Appaji et
al, 2003).
Objectives
The overall goal of this study is to develop a safe, efficacious live attenuated ESC
vaccine that is practical and economically beneficial to catfish producers. The hypothesis
is that combinations of mutations in genes encoding TCA cycle enzymes and glycine
cleavage system proteins will result in a safe, efficacious vaccine for ESC. The specific
objectives of the study include:
1. Constructing new single gene deletion mutations and determining
virulence in channel catfish,
2. Constructing combinations of gene deletions and determining virulence in
channel catfish,
3. Conducting vaccine safety and efficacy testing, and determining tissue
distribution, and
4. Understanding the mechanism of attenuation in a sdhC deletion mutant.
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To achieve the first and second objective, single and double in-frame deletion
mutations were constructed in genes encoding TCA cycle enzymes and C-1 metabolism
proteins. The degree of attenuation of mutants was then determined in juvenile catfish.
Bioluminescence imaging was utilized to quantify degree of attenuation.
To achieve the third objective, vaccine efficacy was tested under controlled
laboratory conditions using juvenile catfish. Efficacy testing was then conducted in 10-14
day old catfish fry. Vaccine efficacy was determined using the standard comparison of
percent survival of vaccinated vs. unvaccinated fish. Tissue distribution of selected
mutants (based upon from vaccine efficacy results) was determined in juvenile catfish.
To achieve the fourth objective, the effect of sdhC deletion and other TCA cycle
enzyme deletions on endogenous superoxide production was determined. Enzyme
activity was confirmed. The anaerobic and aerobic growth curves for the mutants were
compared to wild-type E. ictaluri. A viability assay was conducted to determine whether
superoxide production would damage the sdhC mutant to cause attenuation.
Significance of the study
The economic impact of ESC on the commercial channel catfish industry is
substantial. According to USDA Census of Agriculture, 2007, the catfish industry
accounted for almost 50 percent of the total estimated value of the aquaculture industry
during 2002-2007. However, the channel catfish industry is currently facing severe
economic stress from increased feed prices and pressure from foreign competition. E.
ictaluri is a primary pathogen that affects all sizes classes of fish, and it often predisposes
secondary infections with other pathogens such as Flavobacterium columnare. The
resulting morbidities and mortalities along with decreased production lead to
15

considerable economic losses to channel catfish producers. By developing an effective
vaccine against ESC and consequently reducing catfish losses resulting from ESC, this
study aims to improve the long-range sustainability and competitiveness of the U.S.
channel catfish aquaculture industry, allowing for increased profitability and competitive
edge for catfish farmers in the United States. In addition, studying the effects of deletion
mutations in E. ictaluri TCA cycle enzymes on superoxide production would provide
important information for understanding the relation between superoxide production and
pathogenesis at the molecular level. This study will delineate the mechanism of
attenuation in sdhC mutant.
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CHAPTER II
TRICARBOXYLIC ACID CYCLE AND ONE-CARBON METABOLISM
PATHWAYS ARE IMPORTANT IN EDWARDSIELLA ICTALURI
VIRULENCE

Abstract
Edwardsialla ictaluri is a Gram-negative facultative intracellular pathogen
causing enteric septicemia in channel catfish. The disease causes considerable economic
losses in the commercial catfish industry in the United States, and an efficient treatment
method is not available. Although antibiotics are used as feed additive, vaccination is a
better alternative for prevention of the disease. In general, live attenuated vaccines offer
the best prospect for a vaccine. Here, we report the development and characterization of
novel live attenuated E. ictaluri mutants. To accomplish this, in-frame deletions were
constructed in tricarboxylic acid cycle (sdhC, mdh, and frdA), and one-carbon
metabolism genes (gcvP and glyA) in the chromosome of wild-type E. ictaluri by allelic
exchange. Following bioluminescence tagging of the E. ictaluri ΔsdhC, Δmdh, ΔfrdA,
ΔgcvP, and ΔglyA mutants, their dissemination, attenuation, and vaccine efficacy were
observed in catfish fingerlings by in-vivo imaging technology. Immunogenicity of each
mutant was also determined in catfish fry. Results indicated that all of the E. ictaluri
mutants were attenuated significantly in catfish compared to the parent strain as
evidenced by a 2265.27-fold average reduction in bioluminescence signal from all the
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mutants (relative to wild type) at 144 h post-infection. The catfish immunized with E.
ictaluri ΔsdhC, Δmdh, ΔfrdA, and ΔglyA mutants showed high protection (relative
percent survival (RPS) = 100%) while E. ictaluri ΔgcvP vaccinated catfish showed
medium protection (RPS = 31.23%) after re-challenge with the wild-type E. ictaluri
strain.
Introduction
The channel catfish, Ictalurus punctatus, industry is the largest aquaculture
industry in the United States, and enteric septicemia of catfish (ESC), caused by the
Gram-negative Edwardsiella ictaluri, is the most prevalent disease affecting this industry.
Although Romet® 30, Terramycin®, and Aquaflor® are approved antibiotics to treat
infections in aquaculture, their oral delivery in form of medicated feed is not effective as
fish develop anorexia at early stages of the infection. Also, antibiotic resistant E. ictaluri
strains can emerge (Dung et al., 2008). Therefore, vaccination against E. ictaluri has been
the preferred method for prevention of ESC. Live attenuated vaccines can provide
effective protection against certain diseases because they can express protective antigens
without causing infection in the host (Lan et al., 2007). Identification of genes that are
essential for bacterial virulence can provide new targets for defined non-reverting
mutations.
Chondroitinase (Cooper et al., 1996) and auxotrophic (aroA and purA)
(Lawrence, 1997; Thune et al., 1999) mutants of E. ictaluri have been developed as live
attenuated vaccine candidates. Although the aroA mutant is attenuated and highly
immunogenic, it is not in commercial production. The commercial vaccine Aquavac-ESC
(RE-33) was developed by selecting for rifampin resistance (Klesius and Shoemaker,
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1999). However, antibiotic resistance is not a desired trait for a vaccine. In addition, the
genetic basis for attenuation in RE-33 is undefined (Klesius and Shoemaker, 1997),
although it is known that RE-33 expresses shortened LPS O side chains (Arias et al.,
2003). Despite the availability of Aquavac-ESC, ESC is still the most prevalent disease in
the catfish industry (Annonymous, 2006; USDA, 2003), which stimulates the search for
more effective vaccines.
E. ictaluri is considered a facultative intracellular pathogen, and it is capable of
surviving inside channel catfish neutrophils and macrophages (Ainsworth and Dexiang,
1990; Booth et al., 2006). Although E. ictaluri is effectively phagocytosed by catfish
neutrophils, it is only killed by neutrophils to a limited extent (Ainsworth and Dexiang,
1990; Waterstrat et al., 1988). A recent study by Karsi et al. (Karsi et al., 2009) has
shown that genes encoding tricarboxylic acid (TCA) cycle enzymes, glycine cleavage
system, a sigmaE regulator, the SoxS oxidative response system, and a plasmid-encoded
type III secretion system (TTSS) effector are important for survival in neutrophils (Karsi
et al., 2009). The same study discovered that some neutrophil-susceptible E. ictaluri
strains were highly attenuated and demonstrated very good potential as live attenuated
vaccines.
In particular, strains with insertion mutations in TCA cycle enzymes succinate
dehydrogenase (SdhC) (EiAKMut5) and malate dehydrogenase (Mdh) (EiAKMut12)
generated better protection than the available commercial vaccine when juvenile catfish
were vaccinated by immersion (Karsi et al., 2009). Recently, it was shown that a full
TCA cycle is required for Salmonella enterica virulence, and a sdhDCA mutant is
attenuated in an oral mouse infection model (Tchawa Yimga et al., 2006). In Salmonella,
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mdh mutants were avirulent and highly attenuated in the mouse oral challenge model
(Tchawa Yimga et al., 2006). E. ictaluri glycine dehydrogenase (encoded by gcvP) has
also been linked to virulence (Karsi et al., 2009). This enzyme is part of the glycine
cleavage system, which participates in one-carbon (C1) metabolism. Therefore, the
objective of this research was to introduce in-frame deletions in E. ictaluri genes in the
TCA cycle and C1 metabolism system and determine their role in E. ictaluri virulence.
Materials and methods
Ethics statement
All fish experiments were conducted in accordance with a protocol approved by
the Institutional Animal Care and Use Committee (IACUC) at Mississippi State
University.
Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this work are listed in Table 2.1. E. ictaluri
was grown at 30 oC using brain heart infusion (BHI) broth and agar (Difco, Sparks, MD).
Escherichia coli were grown at 37 oC using Luria-Bertani (LB) broth and agar (Difco). E.
coli CC118 λpir and SM10 λpir/S17-1 λpir were used in cloning and transfer of suicide
plasmid pMEG-375 and pAKgfplux1, respectively. Ampicillin was used at 100 μg/ml to
maintain pMEG-375 and pAKgfplux1. Colistin was used at 12.5 μg/ml for
counterselection against E. coli SM10 λpir following conjugation.
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Table 2.1

Bacterial strains and plasmids.

Strain
Edwardsiella ictaluri
93-146
EiΔfrdA
EiΔgcvP
EiΔglyA
EiΔsdhC
EiΔmdh
Escherichia coli
CC118 λpir
SM10 λpir
S17-1 λpir
Plasmids
pMEG-375
pEiΔfrdA
pEiΔgcvP
pEiΔglyA
pEiΔsdhC
pEiΔmdh

Relevant Characteristics

References

Wild type; pEI1+; pEI2+; Colr
93-146 derivative; pEI1+; pEI2+; Colr; ΔfrdA
93-146 derivative; pEI1+; pEI2+; Colr; ΔgcvP
93-146 derivative; pEI1+; pEI2+; Colr; ΔglyA
93-146 derivative; pEI1+; pEI2+; Colr; ΔsdhC
93-146 derivative; pEI1+; pEI2+; Colr; Δmdh

(Lawrence, 1997)
This study
This study
This study
This study
This study

Δ(ara-leu); araD; ΔlacX74; galE; galK; phoA20; thi-1;
rpsE; rpoB; argE(Am); recAl; λpirR6K
thi; thr; leu; tonA; lacY; supE; recA; ::RP4-2-Tc::Mu; Kmr;
λpirR6K
RP4-2 (Km::Tn7, Tc::Mu-1), ΔuidA3::pir+, recA1, endA1,
thi-1,hsdR17, creC510

(Herrero et al., 1990)

8142 bp, Ampr, Cmr, lacZ, R6K ori, mob incP, sacR sacB
10242 bp, ΔfrdA, pMEG-375
12231 bp, ΔgcvP, pMEG-375
14276 bp, ΔglyA, pMEG-375
16295 bp, ΔsdhC, pMEG-375
18350 bp, Δmdh, pMEG-375

(Dozois et al., 2003)
This study
This study
This study
This study
This study

(Miller and
Mekalanos, 1998)
(Mai et al., 2012)

Construction and bioluminescence tagging of in-frame deletion mutants
The overlap extension PCR method (Horton et al., 1990) was used to generate the
in-frame deletion mutations of E. ictaluri sdhC, mdh, frdA, gcvP, and glyA genes. Four
primers were designed for each gene including forward (lflp), internal-reverse (lfrp),
internal forward (rflp), and reverse primers (rfrp) (Table 2.2). Restriction sites were
included in forward and reverse primers. Genomic DNA was isolated from E. ictaluri
using a Wizard Genomic DNA Kit (Promega, Madison, WI) and used as template in
PCR. Upper fragments were amplified by forward and internal-reverse primers, while
reverse and internal-forward primers were used to amplify lower fragments. The resulting
upper and lower PCR products were gel extracted using a QIAquick Gel Extraction Kit
(Qiagen, Valencia, CA), mixed in a 1:1 ratio, and then re-amplified using the forward and
reverse primers. The resulting in-frame deleted fragment was purified using a QIAquick
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Gel Extraction Kit (Qiagen, Valencia, CA). The purified PCR product was digested with
respective restriction enzymes (Promega) (Table 2.1) and cleaned using a Wizard SV Gel
and PCR Clean-Up Kit (Promega).
The suicide plasmid pMEG-375 was purified from an overnight E. coli culture by
a QIAprep Spin Miniprep Kit (Qiagen) and cut with restriction enzymes respective to the
inserts, producing compatible ends. The purified PCR product with in-frame deletion was
ligated into pMEG-375 vector by T4 DNA Ligase (Promega) at 4 ºC overnight,
generating pEiΔsdhC, pEiΔmdh, pEiΔfrdA, pEiΔgcvP, and pEiΔglyA (Table 2.1). Insert in
each plasmid was confirmed by enzyme digestion as well as sequencing.
The suicide plasmids with in-frame deleted genes were transferred into E. coli
SM10 λpir/S17-1 λpir by electroporation and were mobilized into E. ictaluri 93-146 by
conjugation. The recipient cells were spread on BHI plates containing colistin (12.5
μg/ml) and ampicillin (100 μg/ml) to select the clone with integrated vector by single
crossover through allelic exchange. The ampicillin resistant colonies were propagated on
BHI plates to allow for the second crossover allelic exchange, and resulting colonies were
streaked on LB plates with 5% sucrose, 0.35% mannitol, and colistin (12.5 μg/ml). These
plates selected for loss of pMEG-375 with sacB gene. Colonies from the selective plates
were tested for ampicillin sensitivity to ensure loss of the plasmid. Deleted region was
amplified from the resulting ampicillin sensitive colonies and confirmed by sequencing.
After confirmation, EiΔsdhC, EiΔmdh, EiΔfrdA, EiΔgcvP, and EiΔglyA mutants were
labeled with bioluminescence using pAKgfplux1 as described in Karsi and Lawrence
(Karsi and Lawrence, 2007).
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Table 2.2
Genes
frdA

gcvP

glyA

sdhC

mdh

Primers with restriction enzyme used for the construction of the E. ictaluri
mutants.

Primer ID
EifrdAlflp
EifrdAlfrp
EifrdArflp
EifrdArfrp
EifrdA01S
EigcvPlflp
EigcvPlfrp
EigcvPrflp
EigcvPrfrp
Eigcvp01S
EiglyAlflp
EiglyAlfrp
EiglyArflp
EiglyArfrp
EiglyA01S
EisdhClflp
EisdhClfrp
EisdhCrflp
EisdhCrfrp
EisdhC01S
Eimdhlflp
Eimdhlfrp
Eimdhrflp
Eimdhrfrp
Eimdh01S

Primer Sequence ((5'→3')a
AAGAGCTCTCGTCCACTTCATTCATCAGAC
GTGGAAGTGGAAATCGAAAGA
TCTTTCGATTTCCACTTCCACGAAGCTCAGGAAGCCAAGAAG
AATCTAGAGCAGGGAGATGATATTGAGGAC
CCTCAACTGAAGATTGCCTTA
AATCTAGACCTTTGGCGTGGAGATATGC
AGCATCACTGTTTTCAAGCTG
CAGCTTGAAAACAGTGATGCTGTAAAGCGCCTGGACGATGT
AAGAGCTCCGGACAGAGACATACCACCAA
GGCCTTTTGGTATGATTTGC
AAGAGCTCGGGCATGGGTCAGTGAATAC
CCACAGCTCGGTATCGTAATC
GATTACGATACCGAGCTGTGGGTGAACGTCTTCCGGTCTATG
AACCCGGGGCCTAGACGATGTCTCCTTGA
GGGCCAGATTTACTCAAAACC
AAGAGCTCCAGCCTCCTTTGGTACTGCTA
GCAAATCCAGATTGACAGGTCT
AGACCTGTCAATCTGGATTTGCGGGTATGGTAAGCAACGCATC
AACCCGGGCCCCATCATGTAGTGACAGGT
CTCAGTCTCGTGGGATTTGC
AAGAGCTCGGCTTTATAATGGCGTGTGG
AGGCAGCTGAGTCTTAAGCAG
CTGCTTAAGACTCAGCTGCCTCTGGGCGAAGACTTTATCAAT
AACCCGGGGGAGCAGGCCCTACAAGACT
CAGCTCGCAATCTGAGTGTT

REb
SacI

XbaI
XbaI

SacI
SacI

SmaI
SacI

SmaI
SacI

SmaI

a

RE stands for restriction enzyme added to the 5' end of the primer sequence
Bold letters at the 5' end of the primer sequence represent RE site added. AA nucleotides
were added to the end of each primer containing a RE site to increase the efficiency of
enzyme cut. Underlined bases in internal primer (rflp) indicate reverse complemented
internal primer (lfrp) sequence.
b

Determination of virulence
Experimental infections were conducted in 40-L challenge tanks supplied with
flow-through dechlorinated municipal water. Water temperature was maintained at 25 ºC
(±2) throughout the experiments. Each experimental group contained triplicate tanks. In
each treatment, 28 specific pathogen free (SPF) catfish fingerlings (14.2± 0.35 cm, 25.45
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± 1.82 g) were randomly allocated (four per tank) between E. ictaluri mutants
(treatment), wild-type E. ictaluri (positive control), and phosphate-buffered saline (PBS)
(negative control). Fish were anesthetized in water containing 100 mg/L MS222 and
injected with approximately 1 x 104 colony forming units (CFU) in 100 μl PBS.
Bioluminescent imaging (BLI) was conducted using an IVIS 100 Imaging System
(Caliper Corporation, Hopkinton, Massachusetts)to measure number of photons emitted
by fish (Karsi et al., 2006). Briefly, catfish were anesthetized in water containing 100
mg/L MS222 and transferred immediately to the photon collection chamber for image
capture. Total photon emissions from the whole fish body were collected for one min.
Following BLI imaging, fish were returned to well-aerated water for recovery. BLI was
conducted at 2, 4, 8, and 24 h post-infection and subsequent daily intervals until168 h
post-infection. Bioluminescence was quantified from the fish images using Living Image
Software v 2.5 (Caliper Corporation., Hopkinton, Massachusetts) and quantitative data
were used in statistical analysis.
Determination of efficacy
Catfish fingerlings vaccinated with the E. ictaluri mutants were infected with
wild-type E. ictaluri strain 93-146, and infections were monitored using BLI. Briefly,
after four weeks, the juvenile catfish vaccinated with mutants (described above in the
virulence challenge) were immersion challenged with 4.8 x107 bioluminescent wild-type
E. ictaluri parent strain. Photon emissions from fish were collected at 2, 4, 8, 24, 48, 72,
and 96 h post-infection using an IVIS 100 as described above, and statistical analysis was
performed on the mean photon counts.
29

Determination of vaccine potential
Approximately 420 eight-month-old SPF channel catfish fingerlings (17.61± 0.63
cm, 47.47± 5.31 g) were stocked in 21 tanks at a rate of 20 fish/tank. Each treatment had
three replicate tanks. Vaccination treatments consisted of EiΔsdhC, EiΔmdh, EiΔfrdA,
EiΔglyA, and EiΔgcvP, and controls consisted of Ei wild-type (positive control) and
uninoculated BHI (negative control) respectively. Channel catfish were vaccinated by
immersion challenge in water containing approximately 4.3 x 107 CFU/ml of water for 1
h, followed by gradual removal of bacteria. Mortalities were recorded for 21 days
following the vaccination, then both vaccinated and non-vaccinated treatments were
immersion exposed to wild-type parent E. ictaluri strain 93-146 (approximately 3.06 x
107 CFU/ml). Fish mortalities were recorded daily for 14 days. Relative percent survival
(RPS) was calculated according to the following formula: RPS= [1-(% mortality of
vaccinated fish/% mortality of non-vaccinated fish)] x 100 (Amend, 1981).
Statistical analysis
Photon counts were transformed by taking the base 10 logarithm to improve
normality. One-way ANOVA was conducted using SPSS V19 (IBM Corp., Armonk,
NY) to compare mean photon counts at each time point (p < 0.05). Pairwise comparison
of the means was done using Tukey procedure. Data was then retransformed for
interpretation.
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Results
Construction of the E. ictaluri in-frame deletion mutants
Five in-frame mutants (EiΔsdhC, EiΔmdh, EiΔfrdA, EiΔgcvP, and EiΔglyA) were
obtained successfully (Fig. 2.1) by deleting on average over 90% of each gene (Table
2.3).

Genotypic confirmation of the E. ictaluri gcvP, frdA, mdh, sdhC, and glyA
mutants.

Figure 2.1

Genomic DNAs was amplified from wild-type E. ictaluri and mutants using the two
outside primers (lflp and rfrp) and separated on 1% agarose gel.
Table 2.3

Properties of selected E. ictaluri TCA cycle and C1 metabolism genes and
percentage of gene deleted.

Gene

Locus

sdhC

NT01EI_2872 Succinate dehydrogenase, cytochrome
b556 subunit, putative
NT01EI_0446 Malate dehydrogenase, NAD-dependent, 939/312
putative
NT01EI_0392 Fumarate reductase, flavoprotein subunit, 1800/899
putative
NT01EI_3351 Glycine dehydrogenase, putative
2884/960
NT01EI_3190 Serine hydroxymethyltransferase, putative 1254/417

mdh
frdA
gcvP
glyA

Product

ORF
(bp/aa)
390/129

Remaining % Deletion
(bp/aa)*
57/18
86.05
99/32

89.74

126/41

95.44

114/37
75/24

96.15
94.24

*Number of bp/aa remaining from genes following deletion by overlap extension PCR
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Determination of virulence in juvenile catfish
BLI results revealed that photon counts from the catfish infected with EiΔsdhC,
EiΔmdh, EiΔfrdA, EiΔgcvP, and EiΔglyA mutants were low at 2, 6, and 12 h. However,
the signal intensities for mutants EiΔsdhC, EiΔmdh, EiΔfrdA and, EiΔgcvP increased
from 24 h to 72 h and then decreased thereafter. In mutant EiΔglyA, very low signal was
detected at all time points. The signal intensity increased in fish infected with wild-type
E. ictaluri until all fish died (Fig. 2.2). The bioluminescence signal intensity was 14.4
fold higher in the wild-type infected fish than the average signal from the mutant infected
fish at 72 h post-infection. At 144 h post-infection, average signal from wild-type
infected fish was 2265.27-fold than average signal from the mutant infected fish (Fig.
2.2). The bioluminescence signal intensities were 118.70- and 5329.15-fold less in
EiΔglyA compared to wild-type E. ictaluri at the same time points (Fig. 2.2). In the wildtype group, two fish died at 144 and 168 h post-infection. Mean signal intensities
between all mutants (except EiΔfrdA) and the wild-type strain were significantly different
(p < 0.5) at 24 h post-infection and thereafter.
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Figure 2.2

Bioluminescence imaging of catfish fingerlings experimentally infected
with wild-type or mutant E. ictaluri by intraperitoneal injection.

(A) BLI imaging of catfish. (B) Total photon emissions from each fish.Each data point
represents the mean photon emissions from four fish. Two of the four channel catfish
injected with wild-type died at 144 h post-infection. The remaining two died at 168 h
post-infection. Star indicates significant difference between the E. ictaluri mutants and
wild type.
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Protection against E. ictaluri infection
Photon counts were significantly lower (p < 0.5) at each time point for the
vaccinated fish infected with the E. ictaluri mutants compared to the sham-vaccinated
control (Fig. 2.3). The bioluminescence signal intensity was on average 10-fold higher in
sham-vaccinated fish at 6 h, which increased to 20-fold at 96 h. At this time point, signal
intensity in EiΔsdhC, EiΔmdh, and EiΔfrdA vaccinated fish were in decline while that of
in EiΔgcvP and EiΔglyA vaccinated fish were increasing (Fig. 2.3). At 96 h postinfection, all fish in the sham vaccinated group died.
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Figure 2.3

Bioluminescence imaging of vaccine efficacy in live catfish after wild-type
E. ictaluri infection by immersion.

(A) BLI imaging of catfish. (B) Mean photon emissions from fish.Each data point
represents the mean photon emissions from four fish. Stars indicate significant difference
between mutants and wild-type E. ictaluri.
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Determination of vaccine potential in catfish
Vaccination of channel catfish with EiΔsdhC, EiΔmdh, EiΔfrdA, and EiΔglyA
provided complete protection (100% survival) against wild-type E. ictaluri infection
while the EiΔgcvP mutant showed lower efficacy (68.89% survival) (Fig. 2.4). Survival
rate in EiΔsdhC, EiΔmdh, EiΔfrdA and EiΔglyA vaccinated groups were 1.96-fold higher
than that of the non-vaccinated group when re-challenged with wild-type E. ictaluri
(100% vs. 51.11%).

Figure 2.4

Percentage survival of immersion vaccinated catfish.

The catfish fingerlings were vaccinated with EiΔmdh, EiΔsdhC, EiΔfrdA, EiΔglyA, and
EiΔgcvP mutants and challenged with wild-type E. ictaluri strain 93-146. Fish mortalities
were used to calculate vaccine efficacies.
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Discussion
The primary objective of this study was to construct live attenuated E. ictaluri
strains based on the mutation of genes mdh, sdhC, and frdA, which encode enzymes in
the TCA cycle, and gcvP and glyA, which encode enzymes in C1 metabolism. Further,
we aimed to characterize these mutants in terms of their attenuation in catfish and ability
to protect against wild-type E. ictaluri infection. In our study, we were able to delete
large portion of each gene (on average more than 90% of each gene was deleted) using
splicing overlap extension combined with allelic exchange. This work represents one of
the few successful applications of this technique in E. ictaluri (Abdelhamed et al., 2013;
Santander et al., 2010).
Virulence testing was first conducted in juvenile catfish because it represents a
more reliable challenge system than catfish fry. In addition, catfish fry are only available
once a year in early summer. In juvenile catfish, we utilized bioluminescence imaging to
improve our ability to quantify degree of attenuation. In mutant strains EiΔsdhC,
EiΔmdh, EiΔfrdA, and EiΔgcvP bioluminescence signals were detected after 12 h postinfection, clearly indicating they retain the ability to invade channel catfish. However,
channel catfish injected with the mutant strains were able to start clearing the bacteria
after 72 h post-infection, demonstrating that the mutants were not able to sustain infection
and were all attenuated compared to wild-type E. ictaluri. Comparison of the current
results to an earlier study (Karsi et al., 2006) indicates that bacterial tissue concentration
of 1 x 109 photons-1 cm-2 steradian-1 seems to be a critical threshold after which fish start
dying. The ability of mutants to establish infection for 72 h suggests that the mutants
may have the ability to stimulate an immune response and hence protection against wild37

type E. ictaluri. Because the Ei∆glyA mutant could not persist in host as well as other
mutants after injection vaccination, we would expect much less systemic protection from
this mutant.
After the virulence and protection trial, vaccine potential was determined in
catfish fingerlings. Efficacy result showed that percentage survival was 100% in the
mutant strains EiΔsdhC, EiΔmdh, EiΔfrdA, and EiΔglyA. The percent survival in
EiΔgcvP vaccinated group was 68.89% (Fig. 2.4). Similar results were reported in a
previous study (Karsi et al., 2006), where insertion mutation in genes encoding sdhC and
mdh were found to give 100% and 98.96% protectionagainst E. ictaluri infection,
respectively, while 10.85% mortalities were observed in fish vaccinated with a gcvP
mutant.
Protection seen in fish vaccinated by immersion (fish survival) was very similar to
that obtained by injection vaccination (bioluminescence signals), except that EiΔglyA
vaccination seemed to provide better protection by immersion vaccination (Fig. 2.4). It is
possible that the different protection levels provided by EiΔglyA is caused by different
vaccination routes (injection or immersion). In addition, the method of detection could
cause differences. For example, with injection vaccination, mucosal immune response
may not be fully achieved. It is possible that immersion vaccination using EiΔglyA may
activate mucosal immunity better, preventing wild-type E. ictaluri from establishing
infection. This may also indicate that boosting mucosal immunity could be important in
fish vaccination. We see an opposite trend in EiΔgcvP mutant, which protects fish better
when vaccination is applied by injection rather than immersion. In EiΔgcvP immersion
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vaccination, it is possible that systemic immune response may not be triggered
completely due to low penetration of the mutant into fish body.
Succinate dehydrogenase (SDH) is part of the aerobic respiratory chain in the
TCA cycle, oxidizing succinate to fumarate while reducing ubiquinone to ubiquinol
(Maklashina et al., 1998). It is closely related to fumarate reductase, which catalyzes the
reverse reaction. Succinate dehydrogenase and fumarate reductase can replace each other
(Guest, 1981; Maklashina et al., 1998). Although SdhC has similar function,
hydrophobicity, and protein size to the membrane-binding subunit fumarate reductase
(FrdC), sdhC and frdC do not share significant sequence identity (Wood et al., 1984). The
organic acids formate and succinate have a protective effect in stationary phase cells
against killing effects of antimicrobial peptide BPI, which appears to disrupt the bacterial
respiratory chain (Barker et al., 2000). Maintenance of protective levels of formate and
succinate requires the activity of formate dehydrogenase and succinate dehydrogenase,
respectively.
In E. coli and Salmonella, succinate dehydrogenase is known to contribute to
pathogenicity. Recently, it was shown that a full TCA cycle is required for Salmonella
enterica virulence, and a sdhDCA mutant is attenuated in an oral mouse infection model
(Tchawa Yimga et al., 2006), which is similar to our finding. In Helicobacter pylori,
fumarate reductase was found to be essential for colonization of mouse gastric mucosa
(Ge et al., 2000b). Our results indicated that deletion of the E. ictaluri, sdhC and frdA
genes resulted in full attenuation in catfish fingerlings. Thus, succinate dehydrogenase
and fumarate reductase play an important role in E. ictaluri pathogenesis. Malate
dehydrogenase is encoded by mdh gene, and our results show that mdh is important in E.
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ictaluri virulence. Similarly, an mdh mutant was found to be avirulent and highly
attenuated in Salmonella using the mouse oral challenge model (Tchawa Yimga et al.,
2006).
The glycine cleavage system is a loosely associated four subunit enzyme complex
that catalyzes the reversible oxidation of glycine to form 5- and 10methylenetetrahydrofolate, which serves as a one carbon donor. It is one of two sources
of C1 units; serine hydroxymethyltransferase is the other source, and it is actually
considered the more important source. Expression of the glycine cleavage enzyme system
is induced by glycine (Meedel and Pizer, 1974; Stauffer et al., 1994), and gcv mutants are
unable to use glycine as a C1 source and excrete glycine (Plamann, 1983). Our previous
work as well as this current work have shown that knocking out the E. ictaluri gcvP gene
affects the virulence of E. ictaluri.
Although BLI for real-time monitoring of E. ictaluri infection in live fish was
shown by our group (Karsi et al., 2006), this is the first time we report the use of BLI to
quantify the degree of E. ictaluri attenuation in channel catfish. It appears that BLI could
be used for vaccine evaluation by using very low number of fish (four fish in this work).
In addition, use of BLI has provided evidence for the importance of mucosal immunity in
catfish.
In summary, our results showed that the Ei∆sdhC, Ei∆mdh, Ei∆frdA, Ei∆gcvP,
and Ei∆glyA mutants were significantly attenuated and provided protection against ESC
under controlled laboratory conditions. The significant attenuation of Ei∆sdhC, Ei∆mdh,
Ei∆frdA, and Ei∆gcvP mutants indicate that they may be used safely as live attenuated
vaccine for vaccinating catfish fingerlings. The E. ictaluri ∆glyA mutant was found to be
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incapable of persisting in catfish when injected, which might be the reason for low level
of protection. In contrast, immersion vaccination with the Ei∆glyA mutant seems to give
better protection.
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CHAPTER III
CONSTRUCTING COMBINATIONS OF MUTATIONS IN TRICARBOXYLIC ACID
AND ONE-CARBON METABOLISM PATHWAYS ENZYMES IN
EDWARDSIALLA ICTALURI AND TESTING THEIR
VIRULENCE IN CHANNEL CATFISH

Abstract
Edwardsiella ictaluri is the causative agent of enteric septicemia of Catfish
(ESC), the most economically important disease of farm-raised channel catfish. Different
approaches have been discovered to develop a live attenuated vaccine but the results were
not consistent. Aqavac-ESC is a commercial vaccine on the market, but catfish farmers
still suffer from economic loss due to ESC. In this chapter, we report construction of
EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and EiΔglyAΔgcvP mutants. Deletion
mutagenesis by allelic exchange was used, and virulence and vaccine efficacy were
evaluated using in vivo bioluminescence imaging system (BLI) in catfish fingerlings. All
of the mutants were attenuated; there was 6736-fold average reduction in
bioluminescence signal from all the mutants at 96 h post-infection compared to wild-type
strain 93-146. When catfish fingerlings were vaccinated by injection, all the mutants were
effective in protecting channel catfish against subsequent infection with virulent E.
ictaluri 93-146 strain via immersion route. Vaccination with EiΔfrdAΔsdhC,
EiΔmdhΔsdhC, EiΔgcvPΔsdhC, and EiΔglyAΔgcvP by immersion provided significant
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protection against subsequent immersion challenge with virulent parent strain. In
particular, channel catfish fingerlings vaccinated with EiΔfrdAΔsdhC, EiΔmdhΔsdhC,
EiΔgcvPΔsdhC, and EiΔglyAΔgcvP mutants showed 100% survival following immersion
challenge with virulent wild-type E. ictaluri.
Introduction
In the United States, the largest aquaculture industry is the channel catfish
industry, and the most serious disease affecting this industry is enteric septicemia of
catfish (ESC) (Lawrence at al., 1997). Catfish production accounts for 85 to 90 % of total
commercial finfish production in the United States, and significant losses due to ESC
were reported on over 60% of all farms in operation (Thune et al., 2007). ESC occurs in
one of two forms: an acute form, which is characterized by enteritis and septicemia, and a
chronic form, which is characterized by meningoencephalitis (MacMillan, 1985; Newton
et al., 1989; Shotts et al., 1986). In the acute form, farmers experience economic losses
due to rapid mortalities (Shotts et al., 1986). In the chronic form, farmers experience
losses due to decreased production, with fish manifesting signs 3 to 4 weeks after an
acute outbreak (Newton et al., 1989).
The only treatments currently approved in the U.S. for treatment of ESC are
sulfadimethoxine/ormetoprim and florfenicol (McGinnis et al., 2003), which are
delivered orally as medicated feed. However, antibiotic therapy is not considered the best
management practice for several reasons, including potential development of antibiotic
resistant E. ictaluri strains (Johnson, M.J., 1991). Moreover, one of the earliest clinical
signs associated with ESC is anorexia; therefore, these antibiotics are only effective in
limiting the spread of an outbreak and not in treating the disease.
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An alternative strategy to preventing ESC is vaccination. Live attenuated
vaccines can provide effective protection against certain diseases because they can
express protective antigens without causing morbidity in the host (Lan et al., 2007).
Commercial vaccine Aquavac-ESC generates protective immunity in fry as young as 7 d
post-hatch (Shoemaker et al., 1999). It also provides some protection when used to
vaccinate eyed eggs (Shoemaker et al., 2002). However, despite the availability of the
commercial vaccine Aquavac-ESC, there has been no reduction in the prevalence of ESC
in the industry.
Therefore, this study aims to develop combinations of in-frame mutation in genes
encoding TCA cycle and C-1 metabolism for the development of an efficacious live
attenuated vaccine. E. ictaluri is considered a good candidate for the development of a
vaccine because the species is composed of a single serotype (Bertolini et al., 1990;
Plumb & Vinitnantharat, 1989). However, there is good evidence that cell-mediated
immunity to E. ictaluri is important for the development of an effective protective
response (Ciembor et al., 1995; Klesius & Sealey, 1995; Thune et al., 1997). Therefore,
killed bacterins have only been efficacious under controlled laboratory conditions when
given by injection (Saeed & Plumb, 1986), and this route of delivery is not practical for
commercial production. When delivered by the immersion or oral route, efficacy of
bacterins has been variable (Saeed & Plumb, 1986; Thune et al., 1993).
The currently available commercial live attenuated vaccine (RE-33, marketed as
Aquavac-ESC by Schering-Plough) was developed by selecting for rifampin resistance,
and the genetic basis for attenuation is undefined (Klesius & Shoemaker, 1997).
However, it is known that RE-33 expresses shortened LPS O side chains (Arias et al.,
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2003). Lawrence and Banes (2005) found that an isogenic O polysaccharide mutant was
only effective when juvenile catfish were vaccinated by IP injection, but not by bath
immersion (Lawrence & Banes, 2005). Our group reported vaccine candidates that have
insertion mutations in genes encoding TCA cycle enzymes and glycine cleavage protein;
these candidates demonstrate potential to substantially improve efficacy compared to RE33 (Karsi et al., 2009).
In Chapter II, we reported the construction of EiΔsdhC, EiΔfrdA, EiΔmdh,
EiΔgcvP, and EiΔglyA in-frame deletion mutants. These mutants were significantly
attenuated when tested in channel catfish compared to the parent E. ictaluri strain using
bioluminescence. Efficacy studies also showed that the constructed mutants EiΔsdhC,
EiΔfrdA, EiΔmdh, and EiΔglyA were able to produce significant protective immunity
against E. ictaluri. Mutant EiΔgcvP provided a lower level of protection. Mutants
EiΔsdhC, EiΔfrdA, EiΔmdh, and EiΔglyA were found to be good candidates as live
attenuated vaccines. In the current study, combinations of in-frame deletions in genes
encoding TCA cycle enzymes and C-1 metabolism proteins were constructed to create
greater attenuation while retaining antigenicity.
Materials and methods
Bacterial strains, plasmids, media, and growth conditions
Bacterial strains and the plasmids used in this work are listed in Table 3.1. E.
ictaluri strain 93-146 was cultured in brain heart infusion (BHI) agar and broth (Difco,
Sparks, MD) at 30ºC throughout the entire study. E. coli strains were cultured on Luria–
Bertani (LB) agar and broth from Difco and incubated at 37ºC throughout the entire
study. When required, antibiotics and reagents from Sigma (St. Louis, MO, USA) were
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added to the culture medium at the following concentrations: ampicillin (Amp: 100
µg/ml), colistin sulfate (Col: 12.5 µg/ml), sucrose (5%), and mannitol (0.35%). E. coli
CC118 λpir and SM10λpir/ S17-1 λpir were used in cloning and transfer of suicide
plasmid pMEG-375 and pAKgfplux1, respectively.
Table 3.1

Bacterial strains and plasmids.

Strain
Edwardsiella ictaluri
93-146
EiΔfrdAΔsdhC
EiΔgcvPΔsdhC
EiΔmdhΔsdhC
EiΔglyAΔgcvP
Escherichia coli
CC118 λpir
SM10 λpir
S17-1 λpir
Plasmids
pMEG-375
pEiΔsdhC
pEiΔgcvP

Relevant Characteristics

References

Wild type; pEI1+; pEI2+; Colr
93-146 derivative; pEI1+; pEI2+; Colr; ΔfrdA; ΔsdhC;
93-146 derivative; pEI1+; pEI2+; Colr; ΔgcvP; ΔsdhC;
93-146 derivative; pEI1+; pEI2+; Colr; Δmdh; ΔsdhC;
93-146 derivative; pEI1+; pEI2+; Colr; ΔglyA; ΔgcvP

(Lawrence, 1997)
This study
This study
This study
This study

Δ(ara-leu); araD; ΔlacX74; galE; galK; phoA20; thi-1;
rpsE; rpoB; argE(Am); recAl; λpirR6K
thi; thr; leu; tonA; lacY; supE; recA; ::RP4-2-Tc::Mu;
Kmr; λpirR6K
RP4-2 (Km::Tn7, Tc::Mu-1), ΔuidA3::pir+, recA1,
endA1, thi-1,hsdR17, creC510

(Herrero et al., 1990)

8142 bp, Ampr, Cmr, lacZ, R6K ori, mob incP, sacR
sacB
16295 bp, ΔsdhC, pMEG-375
12231 bp, ΔgcvP, pMEG-375

(Dozois et al., 2003)

(Miller and
Mekalanos, 1998)
(Metcalf et al., 1994)

This study
This study

Construction of double mutants
E. ictaluri 93-146 EiΔfrdAΔsdhC, EiΔmdhΔsdhC, EiΔgcvPΔsdhC, and
EiΔglyAΔgcvP mutants were constructed using deletion mutagenesis. Plasmid pEiΔsdhC
(Chapter II) was separately mobilized from E. coli S17-1λ pir into EiΔfrdA, EiΔgcvP, and
EiΔmdh, (Chapter II) by conjugation. Similarly, pEiΔgcvP was mobilized from E.coli
S17-1 λ pir into EiΔglyA. Recipient bacteria were spread on BHI plates containing the
antibiotics colistin (12.5 μg/ml) and ampicillin (200 μg/ml) to select the clone that had
integrated the vector by single crossover through allelic exchange. Each clone was
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propagated on BHI plates to allow for the second crossover of allelic exchange. The
resulting colonies were streaked on LB plates with 5% sucrose, 0.35% mannitol, and
colistin (12.5 μg/ml). These plates selected for loss of pMEG-375 vector-encoded sacB
gene. Colonies growing on these selective plates were tested for ampicillin sensitivity to
ensure loss of plasmid by using BHI plates supplemented with ampicillin and colistin.
The resulting ampicillin sensitive colonies were confirmed by PCR using outer primers
lflp and rfrp (Table 3.2). After mutant confirmation, each constructed mutant strain,
EiΔfrdAΔsdhC, EiΔmdhΔsdhC, EiΔgcvPΔsdhC, and EiΔglyAΔgcvP were labeled with
bioluminescence by transferring pAKgfplux1from an E. coli donor strain SM10λ pir by
conjugation as described in Karsi and Lawrence (2007).
Table 3.2

Primers used for confirmation of the E. ictaluri mutants.

Genes

Primer ID

Primer Sequence (5'→3')a

REb

gcvP

EigcvPlflp

AATCTAGACCTTTGGCGTGGAGATATGC

XbaI

EigcvPrfrp

AAGAGCTCCGGACAGAGACATACCACCAA

SacI

EisdhClflp

AAGAGCTCCAGCCTCCTTTGGTACTGCTA

SacI

EisdhCrfrp

AACCCGGGCCCCATCATGTAGTGACAGGT

SmaI

sdhC
a

RE stands for restriction enzyme added to the 5' end of the primer sequence
Bold letters at the 5' end of the primer sequence represent RE site added. The additional
nucleotides (AA) were added to the 5' end of each primer containing a RE site to increase
the efficiency of enzyme cut.
b

Virulence assays
Six-months-old SPF channel catfish fingerlings (14.2± 0.35 cm, 25.45 ± 1.82 g)
were transferred into challenge tanks (4/tank) supplied with flow-through dechlorinated
municipal water. Water temperature was maintained at 28oC throughout the experiments.
Fish were anesthetized in water containing 100 mg/L MS-222, and 1 x 106 CFU of a
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specific strain in 100 μl of phosphate-buffer saline (PBS) was injected by sterile syringe
into each of four channel catfish fingerlings. There were six treatments in this assay: four
vaccination treatments (EiΔfrdAΔsdhC, EiΔmdhΔsdhC, EiΔmdhΔsdhC and
EiΔglyAΔgcvP), positive control treatment (wild-type strain 93-146), and negative
control treatment (PBS).
Bacterial quantification was conducted using the IVIS Imaging System at 2, 4, 8,
and 24 hours post-infection, and subsequent daily intervals. To accomplish this, each fish
was anesthetized in water containing 100 mg/L MS222 and transferred immediately to
the photon collection chamber for image capture. Total photon emissions from the whole
fish body were collected at exposure time of one minute. Following imaging, fish were
returned to well-aerated water for recovery. Bioluminescence images were displayed as
pseudocolor images, and bioluminescence was quantified from the fish images using
Living Image v2.5 software (Caliper Corporation, 2009).
Protection assays
Twenty-one days after experimental infection by injection with EiΔmdhΔsdhC,
EiΔgcvPΔsdhC, EiΔfrdAΔsdhC and EiΔglyAΔgcvP, channel catfish fingerlings were
immersion challenged with 4.8 x107 CFU of bioluminescent wild-type E. ictaluri 93-146.
In each experiment, an age-matched set of sham vaccinated channel catfish fingerlings
were also challenged with 4.8 x107 CFU of bioluminescent wild-type E. ictaluri 93-146.
Bacterial quantification was conducted using the IVIS Imaging System at 2, 4, 8, 24, 48,
72, and 96 hours post-infection using the methods described in section 2.5.
Bioluminescence was quantified from the whole body of each fish, and statistical
analyses were performed using the mean bioluminescence for each treatment.
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Protection against mortalities in juvenile catfish vaccine trial
Approximately 360 eight-month-old SPF channel catfish fingerlings (17.61± 0.63
cm, 47.47± 5.31 g) were stocked into 18 tanks at a rate of 20 fish/tank. Each treatment
had three tank replicates; there were four vaccination treatments (EiΔfrdAΔsdhC,
EiΔmdhΔsdhC, EiΔmdhΔsdhC and EiΔglyAΔgcvP), positive control treatment (wild-type
strain 93-146), and negative control treatment (uninoculated BHI broth). Channel catfish
were vaccinated by immersion challenge in water containing approximately 4.3 x 107
CFU/ml of water for 1 h, followed by gradual removal of bacteria. Mortalities were
recorded for 21 days following vaccination. After 21 days, fish in both vaccinated and
non-vaccinated treatments were immersion exposed to wild-type parent E. ictaluri
(approximately 3.06 x 107 CFU/ml of water), and fish mortalities were recorded daily for
14 days.
Statistical analysis
Photon counts were transformed by taking the base 10 logarithm to improve
normality. One-way ANOVA was conducted using SPSS V19 (IBM Corp., Armonk,
NY) to compare mean photon counts at each time point (p < 0.05). Pairwise comparison
of the means was done using Tukey procedure. Data was then retransformed for
interpretation.
Results
Construction of E. ictaluri double mutants
The four double mutants constructed in this study included EiΔfrdAΔsdhC,
EiΔmdhΔsdhC, EiΔgcvPΔsdhC, and EiΔglyAΔgcvP. Colony PCR from chromosomal
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DNA of the single crossover mutant strains confirmed the presence of two distinct bands
on agarose gel. These results proved integration of the entire plasmid into the E. ictaluri
chromosome and formation of a merodiploid (one intact copy of the gene and one copy
of the gene with a large deletion). LB plus sucrose plates selected for colonies that had
undergone a second crossover event. Deletion mutants were genotypically confirmed by
colony PCR with flanking primers lflp and lflp. Agarose gel analysis of the colony PCR
products confirmed the presence of only the single mutant band, which is smaller than the
E. ictaluri 93-146 band by the amount that was deleted. On average 91.23% of each gene
was deleted; the exact number of bases deleted from each gene is shown in Table 3.3.
Table 3.3

Properties of the E. ictaluri TCA cycle and C1 metabolism genes and
average percent of gene deleted.

Gene
Product
% Deletion
sdhC-mdh Succinate dehydrogenase, cytochrome b556 subunit, putative 87.89
- Malate dehydrogenase, NAD-dependent, putative
sdhC-frdA Succinate dehydrogenase, cytochrome b556 subunit,
90.74
putative- Fumarate reductase, flavoprotein subunit, putative
sdhC-gcvp Succinate dehydrogenase, cytochrome b556 subunit, putative 91.1
- Glycine dehydrogenase, putative
gcvP-glyA Glycine dehydrogenase, putative- Serine
95.19
hydroxymethyltransferase, putative

Determining the degree of attenuation of constructed double mutants
Channel catfish were intraperitoneally injected with 1x106 CFU of wild-type 93146, EiΔfrdAΔsdhC, EiΔmdhΔsdhC, EiΔgcvPΔsdhC, or EiΔglyAΔgcvP. For wild-type
93-146, this dose was fatal for the channel catfish. All four fish died by 168 hours postinfection. Out of four channel catfish that were infected with EiΔfrdAΔsdhC, two were
dead at 144 hours post-infection. A similar result was observed in channel catfish
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infected with EiΔmdhΔsdhC. One mortality was recorded at 144 hours post-infection in
channel catfish infected with EiΔglyAΔgcvP. In contrast, all four channel catfish that
were infected with EiΔgcvPΔsdhC survived at 168 hours post-infection.
BLI results showed that the infection started from the site of IP injection and
disseminated throughout the whole body of the channel catfish by 144 hours postinfection in all the mutants and wild-type E. ictaluri (Fig. 3.1). At 168 hours postinfection, there was an average 30-fold reduction in signal intensity in the mutants
compared with wild type. In wild-type 93-146, the signal intensity was high at 168 hours
post-infection, and all the fish were found dead in the following day. Statistical analysis
revealed that there were no significant differences between the mutants and the wild-type
strain until 144 hours post-infection (P<0.05). At 168 hours post-infection, there were
significant differences between wild-type 93-146 and EiΔglyAΔgcvP (P= 0.022) and
EiΔgcvPΔsdhC (P=0.027).
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Figure 3.1

Mean photon emissions in IP injected channel catfish (1X106 CFU/mutant
and wild type) at indicated time points post-infection.

Total photon emissions from each fish were quantified using living Image software. Each
data point represents the mean photon emissions from four fish. * Two of the four
channel catfish injected with Ei∆frdA∆sdhC died at 144 h post-infection.
Protection against wild-type E. ictaluri 93-146 infection
Results of the protection challenge indicated that the mutants were able to protect
channel catfish against subsequent infection with wild-type E. ictaluri. When the channel
catfish originally infected with 1x106 CFU of EiΔfrdAΔsdhC, EiΔmdhΔsdhC,
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EiΔgcvPΔsdhC, or EiΔglyAΔgcvP were immersion challenged with 4.8 x107 CFU of
wild-type 93-146 28 days later, results showed that the mutants provided protection
against ESC. BLI imaging revealed that signal intensity in vaccinated channel catfish
increased until 48 hours post-infection and then started decreasing from 72 hours postinfection (Fig. 3.2). No mortalities occurred from wild-type E. ictaluri infection in all of
the mutant-exposed fish. However, in sham–exposed channel catfish, signal intensity
increased until 96 hours post-infection, and all the channel catfish died within 120 hours
post-infection. Thus, the EiΔfrdAΔsdhC, EiΔmdhΔsdhC, EiΔgcvPΔSdhC, and
EiΔglyAΔgcvP mutants protected against a challenge with wild-type 93-146 and were
significantly different from the PBS control at 96 hours post-infection (P<0.001).
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Figure 3.2

Mean photon emissions in immersion challenged channel catfish by 93-146
E. ictaluri at indicated time point post-infections.

Channel catfish were immersion challenged in water containing 93-146 E. ictaluri (4.8
x107 CFU/ml). Total photon emissions from each fish were quantified using living Image
software. Each data point represents the mean photon emissions from four fish.
Vaccine trial
Results of the vaccine trial indicated that the constructed mutants EiΔfrdAΔsdhC,
EiΔmdhΔsdhC, EiΔgcvPΔsdhC, and EiΔglyAΔgcvP were efficacious and protected fish
against ESC as evidenced by 100% percent survival (Figure 3.3). All the fish that died
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following exposure to E. ictaluri 93-146 exhibited clinical signs typical of ESC. The
survival rate in vaccinated fish was an average of 1.96-fold higher than that of the nonvaccinated group when re-challenged with wild-type E. ictaluri (100% vs. 51.11%).

Figure 3.3

Percent survival of channel catfish fingerlings vaccinated with
EiΔfrdAΔsdhC, EiΔmdhΔsdhC, EiΔgcvPΔsdhC, and Ei ΔglyAΔgcvP
following experimental immersion challenge with wild-type E. ictaluri.

Discussion
In Chapter II, we showed that the deletion mutants EiΔfrdA, EiΔsdhC, EiΔmdh,
EiΔgcvP, and EiΔglyA were avirulent in channel catfish. Mutants EiΔfrdA, EiΔsdhC, and
EiΔmdh provided protection against subsequent challenge with wild-type 93-146. In the
current study, we aimed to improve the safety and attenuation of these mutants by
constructing combinations of double mutants in TCA cycle enzymes and 1C metabolism
proteins.
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Fumarate reductase and succinate dehydrogenase are physiologically reversible
isoenzymes in the TCA cycle that are induced under anaerobic and aerobic conditions,
respectively (Mercado-Lubo et al., 2007). Malate dehydrogenase is an enzyme that
reversibly catalyzes the oxidation of malate to oxaloacetae using the reduction of NAD+
to NADH (Vogel R.F et al., 1987). Mutations in E. ictaluri TCA cycle genes caused
significant attenuation (Karsi et al., 2009). In particular, the insertion mutants
EiAKmut05 and EiAKmut12, which have mutations in sdhC and mdh genes, were found
to be avirulent and provided good protection against ESC in catfish fingerlings. These
mutants were highly attenuated by immersion challenge in channel catfish fingerlings;
EiAKmut05 caused no mortalities and EiAKmut12 caused 4.45% mortalities compared
to wild-type E. ictaluri, which caused 93.07% mortality (Karsi et al., 2009). However,
when the same mutants were tested in 15 day old catfish fry, the mutants caused
mortalities (data not shown). Therefore, our goal in the current study was to construct
combination mutations to improve the safety of these vaccine candidates.
The EiΔgcvPΔsdhC mutant has a combination of mutations from two different
metabolic pathways: TCA cycle gene sdhC and C1 metabolism protein gene gcvP.
Results from the BLI imaging indicated that the combination of these two pathways
resulted in significant attenuation. EiΔglyAΔgcvP has a combination of mutations in
genes encoding proteins in two different C1 metabolism pathways. This mutant was also
significantly attenuated when compared with wild-type E. ictaluri.
The EiΔfrdAΔsdhC and EiΔmdhΔsdhC mutants were not fully attenuated. In
Salmonella typhimurium, mutation in SR-11 ΔsdhCDA caused slight attenuation, and the
SR-11 ΔfrdABCD mutant was fully virulent (Mercado-Lubo et al., 2008). However,
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mutant SR-11 ΔsdhCDA and SR-11 ΔfrdABCD were combined, the resulting
combination mutant was fully attenuated (Mercado-Lubo et al., 2008). In Chapter II,
when testing the single deletion mutants for attenuation, we used 103 CFU/ml and found
that they were significantly attenuated. However, in the current study, channel catfish
were injected with 106 CFU/ml of each combination mutant, which is 1000-fold more
than what we used for the single deletion mutants. This is likely why there were some
mortalities caused by EiΔfrdAΔsdhC and EiΔmdhΔsdhC. Nevertheless, the subsequent
vaccine trial result showed 100% percent survival for EiΔfrdAΔsdhC and EiΔmdhΔsdhC
vaccinated fish.
The constructed combination mutants EiΔfrdAΔsdhC, EiΔmdhΔsdhC,
EiΔgcvPΔsdhC, and EiΔglyAΔgcvP were not virulent in catfish fingerlings using the
immersion route of exposure. BLI results also showed significant attenuation of these
mutants compared to wild-type E. ictaluri. Current production practices in commercial
catfish production only allow immersion vaccination of channel catfish fry at 10-15 days
old. Fry at this age are more susceptible to ESC than fingerlings. Furthermore, to be
effective, protective immunity must last through summer and fall. Based on these results
in fingerlings, our next goal will be to test these vaccine candidates in 10-14 day old fry.
To develop protective immunity in channel catfish, mutants must persist in the tissues for
some time. Therefore, the ability of the constructed mutants to persist in catfish tissues
will also be examined next.
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CHAPTER IV
TISSUE PERSISTENCE AND VACCINE EFFICACY OF TCA CYCLE AND SINGLE
CARBON METABOLISM MUTANT STRAINS OF EDWARDSIELLA ICTALURI

Abstract
Studies on the tissue persistence and vaccine efficacy of previously constructed
TCA cycle (EiΔsdhC, EiΔfrdA, and EiΔmdh) mutants, single carbon metabolism mutants
(EiΔgcvP and EiΔglyA), and combination mutants (EiΔfrdAΔsdhC, EiΔgcvPΔsdhC,
EiΔmdhΔsdhC, and EiΔgcvPΔglyA) of E. ictaluri were conducted in channel catfish
(Ictalurus punctatus). Mutant strains EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and
EiΔgcvPΔsdhC were able to invade the host and persist in the trunk kidney. Numbers of
bacteria found in catfish trunk kidney tissue were high for all the mutants until 11 days
post-infection, and then they decreased. Vaccination with mutants EiΔsdhC, EiΔfrdA,
EiΔmdh, EiΔgcvP, EiΔglyA, EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and
EiΔgcvPΔglyA by immersion challenge in catfish fingerlings provided substantial
protection against subsequent immersion challenge with the virulent parental strain. All
mutants had 100% percent survival except for the mutants EiΔgcvPΔglyA and EiΔgcvP,
for which the percent survival were greater than 87%. Mutant EiΔsdhCΔgcvP was found
to be very good at protecting catfish fry, as evidenced by 9.9 fold higher percent survival
compared to non-vaccinated fish.
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Introduction
Enteric septicemia of catfish (ESC) is still an important disease of farm-raised
channel catfish (Ictalurus punctatus). In 1999, economic losses due to ESC were
estimated to be as high as $60 million (Klesius and Shoemaker, 1999). In 2010, catfish
farmers operating in Alabama, Mississippi, Arkansas, and Louisiana reported 36.6%
mortality rates due to ESC (U.S. Department of Agriculture 2012). Although
considerable progress has been made in developing live attenuated vaccines (Klesius and
Shoemaker 1999; Lawrence et al. 1997; Thune et al. 1999; Abdelhamed et al. 2013), ESC
is still a major threat to the catfish industry. Until recently, only one vaccine has been
commercially approved for use against ESC.
Live attenuated strains of facultative, intracellular bacterial pathogens should
maintain their ability to invade the host via oral or immersion route, and they are often
effective in developing strong cell mediated immune (CMI) responses (Thune et al.
1999). Karsi et al. (2009) reported that genes encoding TCA cycle enzymes and onecarbon metabolism proteins are required for virulence of E. ictaluri. To better understand
the role of E. ictaluri TCA cycle genes and one-carbon metabolism genes in pathogenesis
and immunity, mutants with in-frame deletions in genes encoding TCA cycle enzymes
(sdhC, mdh, and frdA) and genes encoding one-carbon metabolism proteins (gcvP and
glyA) were constructed (Chapter II). To improve safety of vaccine candidates,
combinations of mutations (sdhC-frdA, sdhC-mdh, sdhC-gcvp and gcvP-glyA) were also
constructed (Chapter III).
The sdhC gene encodes one of the four subunits of the succinate dehydrogenase
(Sdh) complex and oxidizes succinate to fumurate while reducing ubiquinone to
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ubiquinol (Nakamura et al. 1996). Fumrate reductase (frd) catalyzes the reverse reaction
in aerobic respiration (Nakamura et al. 1996). Sdh is known to contribute pathogenicity
in E. coli and Salmonella (Nakamura et al. 1996 and Mercado-Lubo et al. 2008).
Mercado-Lubo et al. (2008) reported slight attenuation of a ΔsdhCDA mutant in S.
enterica serovar Typhimurium. They also showed that a ΔfrdABCD mutant was fully
virulent. However, they achieved complete attenuation by constructing a sdh and frd
double mutation. Malate dehydrogenase (encoded by mdh) catalyzes the conversion of
oxaloacetate and malate utilizing the NAD/NADH coenzyme system (Minárik et al.
2002). Using a mouse oral challenge model, Salmonella mdh mutants were avirulent
(Tchawa Yimga et al., 2006). The gcvP gene encodes a protein that is part of the glycine
cleaveage system, and glyA encodes serine hydroxymethyltransferase. To our
knowledge, these two genes have not been linked with virulence in other bacterial
species, but Karsi at al. (2009) showed that the GcvP protein is critical for both
neutrophil and serum resistance in E. ictaluri.
Previously, we determined the degree of attenuation of the TCA cycle and C-1
metabolism protein mutants in channel catfish fingerlings using bioluminescence imaging
(Chapters II and III). We found that the in-frame deletion mutants EiΔsdhC, EiΔfrdA,
EiΔmdh, EiΔgcvP, EiΔglyA, and EiΔgcvPΔsdhC were highly attenuated, whereas mutant
strains EiΔgcvPΔglyA, EiΔfrdAΔsdhC, and EiΔmdhΔsdhC were less attenuated in catfish
fingerlings. However, catfish fingerlings were intraperitoneally injected with the mutants,
which is generally not a favored route of vaccination. In the current study, vaccine
efficacy of mutants was tested in catfish fingerlings and fry by the immersion route,
which is considered the natural and the cost-effective route of vaccination. Therefore, the
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objectives of this study were to determine the tissue persistence and vaccine potential of
TCA cycle and C-1 metabolism mutant strains of Edwardsiella ictaluri by using
immersion challenge.
Materials and methods
Bacterial strains
E. ictaluri 93-146 and EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔgcvP, EiΔglyA,
EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and EiΔgcvPΔglyA were grown at 30°C
on brain-heart infusion (BHI) agar plates. E. ictaluri selective medium (EIM) was used
for the tissue persistence study to quantify E. ictaluri from serially diluted tissue
homogenate. For vaccine challenges, E. ictaluri 93-146 and EiΔsdhC, EiΔfrdA, EiΔmdh,
EiΔgcvP, EiΔglyA, EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and EiΔgcvPΔglyA
were grown in BHI broth for 18 hours at 30°C by shaking at 175 rpm. For the tissue
persistence study, E. ictaluri 93-146 and EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and
EiΔgcvPΔsdhC with pAKgfplux1 plasmid (Karsi et al., 2006) were grown in BHI broth
with ampicillin (100μg/ml) for 18 hours at 30°C by shaking at 175 rpm.
Tissue persistence
240 six-month-old catfish fingerlings were stocked into ten 40-L tanks (24
fingerlings per tank) supplied with flow-through dechlorinated municipal water and the
temperature was maintained at 28 °C throughout the trail. Fish were allowed to acclimate
for a week. After a week, two tanks for each mutant group were experimentally exposed
to EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and EiΔgcvPΔsdhC, and fish in the other two tanks
were exposed to wild-type E. ictaluri 93-146.
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Before exposure, one fish was removed from each tank to establish the baseline
negative control. Experimental immersion exposure was conducted by lowering water
level in each tank to 10-L with aeration, and fish were exposed to bacterial culture
corresponding to 1 x 107 colony formation unit (CFU) per milliliter (ml) of water. After
one hour, water flow was restored to allow gradual removal of the bacteria.
At each time point, three fish were randomly selected and removed from each
tank and euthanatized by transferring to water containing 1 g tricaine methanesulfonate
(Sigma-Aldrich, St. Louis, Missouri) per liter of water. Sampling points were at 2 h, 6 h,
1 d, 2 d, 3 d, 4 d, 5 d, 6 d, 7 d, 9 d, 11 d, 14 d, 17 d, and 21 d post-infection. Trunk kidney
was aseptically removed from each fish and weighed. Bioluminescence was quantified
from the tissue at each time point using an IVIS Imaging System (Caliper Corporation,
Hopkinton, Massachusetts). After imaging, each tissue was suspended in 0.5 ml of sterile
water and macerated. The resulting suspension was serially diluted depending upon the
bioluminescent signal from IVIS imaging, and 15 μl aliquots were spread on EIM plates
for quantification. The colony counts were determined at 48h of incubation. The E.
ictaluri colonies were identified as 0.5-1.0 millimeter (mm) green, translucent colonies
(Shotts and Waltman, 1990). The number of CFU/gm of tissue was calculated for each
fish.
For statistical analysis, the calculated CFU/gm was transformed by taking the
base 10 logarithm to improve normality. To compare mean bacterial concentrations
between strains at each time point, a one-way ANOVA of the transformed data was
conducted using SPSS 19 statistical software (SPSS Inc., 2010). Pairwise comparison of
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the means was done using Tukey procedure at significance level of 0.05. Data was then
retransformed for interpretation.
Vaccine trial
Four-month-old channel catfish were stocked at a rate of 15/tank into 33 40-L
tanks and randomly divided into 11 treatment groups with three tanks per treatment. Nine
of the 11 treatment groups were vaccinated with EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔgcvP,
EiΔglyA, EiΔfrdAΔsdhC, EiΔsdhCΔgcvP, EiΔsdhCΔmdh, and EiΔglyACΔgcvP, and one
of the 11 treatment groups was exposed to E. ictaluri 93-146. One treatment group served
as sham-vaccinated control. Immersion challenge was done by lowering the water level
from each tank to 10-L, and 100 ml of bacterial culture was added to each tank (on
average 3.25 X 107 CFU/ml)) and, 100 ml of BHI media was added to Sham-vaccination
control. After one hour, water flow was restored to each tank. Mortalities in each tank
were recorded for 21 days.
On day 21 post-vaccination, vaccinated and non-vaccinated treatments were
experimentally infected with wild-type E. ictaluri by immersion exposure with a final
bacterial concentration of approximately 3.1 X 107 CFU/ml in water. Water flow was
stopped for one hour following exposure and then resumed after one hour, which allowed
gradual removal of the bacteria. Percent mortalities were determined for each tank after
two weeks.
Vaccine safety in catfish fry
Vaccine safety in catfish fry was determined for each five single and four double
mutants. Briefly, 14 day old specific pathogen free (SPF) catfish fry were transferred into
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42 tanks (approximately 70 fry/tank, three replicates per treatment). Fry were immersion
exposed to two doses (107 CFU/ml and 106 CFU/ml) for combination mutants
(EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and EiΔgcvPΔglyAC) and a single dose
of 107 CFU/ml for single mutants (EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔgcvP, and EiΔglyA).
Fry were immersion exposed to 100 ml of BHI media for sham-vaccination control.
Immersion challenges were conducted for one hour with subsequent gradual removal of
bacteria as described above. Mortalities were recorded daily for 21 days.
On day 21 post-vaccination, all treatments were immersion exposed to parent
strain E. ictaluri 93-146 at approximately 107 CFU/ml using the standard procedure
described above.
Results
Tissue persistence
At each time point until 11 days post-infection, EiΔsdhC, EiΔfrdA,
EiΔfrdAΔsdhC, and EiΔsdhCΔgcvP mutants were isolated on EIM plates from trunk
kidney of catfish. The mean CFU/gm of posterior kidney tissue for EiΔsdhC, EiΔfrdA,
EiΔfrdAΔsdhC, EiΔsdhCΔgcvP mutants, and wild-type E. ictaluri are shown in Figure
4.1. Tissue concentration of wild-typestrain was higher than mutants at 96 h, 120 h, 7 d, 9
d, 11 d, and 14 d post-inoculation. From 5 d to 9 d post-infection, tissue concentrations
were higher for EiΔfrdA and EiΔsdhCΔgcvP compared with EiΔsdhC and
EiΔfrdAΔsdhC. There was no significant difference between the mean concentration of
wild-type E. ictaluri and the mutants EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and
EiΔsdhCΔgcvP 2 h until 7 days post-infection. However, the tissue concentration of
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wild-type E. ictaluri was significantly higher than the concentration of EiΔsdhC,
EiΔfrdA, EiΔfrdAΔsdhC, and EiΔsdhCΔgcvP at 9, 11 and 14 days post-infection.
Bioluminescence detection was less sensitive than CFU/gm determinations to
measure bacterial tissue concentrations. No signal or very low signal was detected in the
tissue of all the mutants at most of the time points except for 24 h to 96 h post-infection
for EiΔsdhC, EiΔfrdA mutants and wild-type E. ictaluri. At these time points,
bioluminescence in kidney tissue was high for these two mutants (data not shown).

Figure 4.1

Mean tissue concentrations (log10 transformed colony forming units per
gram (CFU/gm) of the EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and
EiΔgcvPΔsdhC mutants and wild-type E. ictaluri strain 93-146 in posterior
kidneys of channel catfish at various sampling times following immersion
exposure.

The mean CFU/gm of posterior kidney is not shown for wild-type E. ictaluri at 24 h postinfection due to technical difficulties.
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Vaccine trial
To confirm attenuation of the nine mutants (EiΔsdhC, EiΔfrdA, EiΔmdh,
EiΔgcvP, EiΔglyA, EiΔfrdAΔsdhC, EiΔsdhCΔgcvP, EiΔsdhCΔmdh, and EiΔglyAΔgcvP),
an experimental infection by immersion exposure was conducted in catfish fingerlings.
Mutants EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔfrdAΔsdhC, EiΔsdhCΔgcvP, and
EiΔsdhCΔmdh were found to be subsequently attenuated when compared to wild-type E.
ictaluri (Fig. 4.2A). In fact, no mortalities occurred for these mutants; by comparison,
wild-type E. ictaluri caused 61.61% mortalities. EiΔglyACΔgcvP, EiΔgcvP, and EiΔglyA
were the least attenuated mutants, causing 29.63%, 38.54%, and 40.14% fish mortalities,
respectively (Fig. 4.2A).
Results of the subsequent efficacy trial are presented Fig. 4.2B. Sham-vaccinated
catfish fingerlings had a final percent survival of 47.06%, which is subsequently lower
than the percent survival for mutants EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔglyA,
EiΔfrdAΔsdhC, EiΔsdhCΔgcvP, and EiΔsdhCΔmdh, which had 100% survival. Mutants
EiΔglyACΔgcvP and EiΔgcvP had slightly lower percent survival (94.75%, and 87.98%,
respectively) when compared with the other mutants (Fig. 4.2B). All of the mortalities
had external and internal lesions that were consistent with ESC.
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Figure 4.2

Percent mortalities and survival of channel catfish fingerlings.

(A). Percent mortalities of catfish fingerlings challenged with the EiΔsdhC, EiΔfrdA,
EiΔmdh, EiΔgcvP, EiΔglyA, EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and
EiΔgcvPΔglyAC mutants and wild-type E. ictaluri (B). Percent survival of channel
catfish fingerlings vaccinated with the EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔgcvP, EiΔglyA,
EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and EiΔgcvPΔglyAC mutants and
challenged with wild-type E. ictaluri.
Vaccine safety in catfish fry
Results of the safety trial in catfish fry indicated that combination mutants were
less virulent than single knockout mutants were (Fig. 4.3A). Interestingly, there was one
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exception: combination mutant EiΔfrdAΔsdhC caused higher mortalities than EiΔfrdA.
EiΔfrdA (14% mortalities) was also less virulent than mutant strains EiΔmdh and
EiΔsdhC (63% and 76% mortalities, respectively). Mutant strains EiΔglyA and EiΔgcvP
were fully virulent in catfish fry, causing 100% mortalities (Fig. 4.3A). In combination
mutants, fry challenged with the lower dose (1 x 106 CFU/ml) had lower mortalities than
fry challenged with the standard vaccine dose (1 x 107 CFU/ml). Overall, the safest
vaccine candidates at the 1 x 107 CFU/ml dose were EiΔgcvPΔsdhC and EiΔfrdA.
Preliminary vaccine efficacy of the mutants was determined by challenging
vaccinated fry with parent strain 93-146 by immersion. Protection was better in catfish
fry vaccinated with the higher dose of combination mutants compared to catfish fry
vaccinated with the lower dose (Fig. 4.3B). The best percent survival was in fry
vaccinated with EiΔgcvPΔsdhC which gave 99% protection. Mutant EiΔfrdA also gave
60% protection (Fig. 4.3B).
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Figure 4.3

Percent mortalities and survivals of channel catfish fry.

(A). Percent mortalities of catfish fry challenged with mutants EiΔsdhC, EiΔfrdA,
EiΔmdh, EiΔgcvP, EiΔglyA, EiΔfrdAΔsdhC, EiΔgcvPΔsdhC, EiΔmdhΔsdhC, and
EiΔglyACΔgcvP. (B). Percent survival of catfish fry vaccinated with mutants EiΔsdhC,
EiΔfrdA, EiΔmdh, EiΔgcvP, and EiΔglyA, EiΔfrdAΔsdhC, EiΔgcvPΔsdhC,
EiΔmdhΔsdhC, and EiΔgcvPΔglyA when challenged with the E. ictaluri wild-type strain
Discussion
The primary objective of this study was to determine tissue persistence and
vaccine potential of TCA pathway and single carbon metabolism mutant strains of E.
ictaluri. The tissue persistence study was done using posterior kidney because E. ictaluri
is consistently isolated from this organ (Baldwin and Newton 1993; Lawrence et al. 1997;
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Thune et al. 1999; Lawrence and Banes 2005). Results demonstrated that the TCA
pathway and single carbon metabolism mutant strains EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC,
and EiΔgcvPΔsdhC retained the ability to penetrate channel catfish mucosa and colonize
posterior kidney, indicating that attenuation of the mutant stains in the immersion route of
exposure is not due to its inability to invade the host.
All the mutant strains were isolated from the posterior kidney from 2 h to 22 d
post-exposure. In fact, tissue concentrations were similar between wild-type E. ictaluri
and mutant strain EiΔsdhCΔgcvP from 48 h post-infection to 7 d post-infection. E.
ictaluri auxotrophic mutants ( purA and aroA) (Lawrence et al 1997; Thune et al 1999)
were cleared by 72 h post-infection, whereas 93-146 R6 mutant was found to persist for
14 d post-exposure (Lawrence and Banes 2005). Our results indicated that the
constructed mutants EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and EiΔgcvPΔsdhC were able to
persist as long as wild-type E. ictaluri 93-146 persisted. Studies have suggested that E.
ictaluri can survive and replicate in the macrophage, which might be reason for its longer
persistence time (Baldwin and Newton 1993: Miyazaki and Plumb 1985; Shotts et al
1986). In Salmonella enterica and Yersina pestis, purine and aromatic auxotrophs lost the
ability to survive inside macrophages (Fields et al. 1986; Straley and Harmon 1984);
perhaps that might be the reason why E. ictaluri purA and aroA mutants were cleared by
72 h post-infection (Lawrence et al 1997; Thune et al 1999). Recent studies with
Salmonella typhimurium indicate that mutants with deletion in genes encoding TCA
cycle enzymes have the ability to replicate within resting and activated macrophages,
suggesting an enhanced ability to survive antimicrobial mechanisms (Bowden et al.,
2010). Perhaps EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and EiΔsdhCΔgcvP mutants have the
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ability to survive in channel catfish macrophages, which can partially explain the ability
to persist longer as observed in this study.
For vaccine efficacy, it is important for the mutant to persist longer and achieve
tissue concentration high enough to stimulate protective immunity. The result of the
vaccine trials indicated that immersion vaccination of channel catfish fingerlings with
EiΔsdhC, EiΔfrdA, EiΔmdh, EiΔgcvP, EiΔglyA, EiΔfrdAΔsdhC, EiΔgcvPΔsdhC,
EiΔmdhΔsdhC, and EiΔgcvPΔglyAC mutants provided significant protection against
experimental infection with wild-type E. ictaluri. This is similar to the results reported by
Karsi et al. (2009), which indicated that insertion mutations in TCA cycle genes and
glycine cleavage protein provided significant protection against E. ictaluri in channel
catfish fingerlings.
Results from this study indicated that E. ictaluri mutants with deletions in genes
encoding TCA cycle enzymes and C-1 metabolism proteins retained their ability to
invade catfish fingerlings from water, persisted in the host, and provided significant
protection from ESC by immersion vaccination under controlled laboratory conditions.
In 15 d old catfish fry, mutant combinations improved safety of vaccine candidates. The
mutant Ei ΔgcvP ΔsdhCwas the safest vaccine candidate in catfish fry, and it provided
the best protection against E. ictaluri infection. This finding suggests that future research
should be aimed at adding a mdh or frdA mutation to EiΔgcvPΔsdhC to improve vaccine
safety in channel catfish fry.
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CHAPTER V
UNDERSTANDING THE MECHANISM OF SDHC MUTANT ATTENUATION IN
SUPEROXIDE PRODUCTION

Abstract
Succinate dehydrogenase (SdhCDAB) catalyzes the oxidation of succinate to
fumarate in the TCA cycle, and during the completion of the catalysis process (turnover),
it produces superoxide radicals. In E. coli and some eukaryotes like Caenorhabditis
elegans and yeast, mutations in sdh gene are associated with increased production of
superoxide. The increased production of superoxide may result in metabolic oxidative
stress and genomic instability leading ultimately to cell death. To assess extracellular
superoxide (O2-) production by wild-type E. ictaluri and succinate dehydrogenase
mutants (Ei∆sdhC and Ei∆sdhA), we compared the abilities of these strains to reduce
ferriccytochrome c in the presence and absence of superoxide dismutase (SOD). The
effect of superoxide production on the viability of TCA cycle mutants was determined by
comparing the survivability of sdh and frd mutants with wild-type E. ictaluri in the
presence of hydrogen peroxide. No enhanced superoxide production, as indicated by no
reduction in ferriccytochrome c, was detected in the Ei∆sdhC and Ei∆sdhA mutants. The
viability of Ei∆sdhC mutant decreased by 59.59% in the absence of SOD, and increased
by 79.79% in the presence of SOD.
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Introduction
Succinate dehydrogenase (Sdh), also known as succinate-coenzyme Q reductase
(SQR) or Complex II, is an enzyme complex present in all aerobic cells (Zhao et al.
2006). Sdh is a membrane-bound dehydrogenase linked to the respiratory chain, and it is
a part of the tricarboxylic acid (TCA) cycle (Hajjawi 2011). Its activity is modulated by
several activators and inhibitors, and it has covalently bound FAD (Hajjawi 2011).
In bacteria, Sdh is encoded by sdhCDAB and is a structural homologue of
complex II. In aerobic bacteria, it catalyzes the oxidation of succinate to fumarate in the
TCA cycle and electron transfer from succinate to the ubiquinone pool in the respiratory
chain (Zhao et al., 2006). SdhCDAB consists of 4 subunits: two hydrophilic and two
hydrophobic. The first two subunits, a flavoprotein (SdhA) and an iron-sulfur protein
(SdhB) are hydrophilic (Nakamura et al. 1996). SdhA contains a covalently attached
FAD cofactor and the succinate binding site. SdhB contains three iron-sulfur clusters:
[2Fe-2S], [4Fe-4S], and [3Fe-4S]. The second two subunits are hydrophobic membrane
anchor subunits, SdhC and SdhD (Page et al., 1999).
Recent studies have suggested that mutations in the gene encoding SdhC cause an
increase in O2- production, metabolic oxidative stress, and genomic instability in hamster
fibroblasts (Slane et al., 2006). Ishii et al. (2005) showed that a point mutation within the
coenzyme Q (CoQ) binding site of mev-1 (homologous to SdhC) leads to rapid aging and
hypersensitivity to oxygen toxicity in C. elegans. Similarly, Zhao et al. (2006) found
enhanced superoxide production in site-directed mutations around the heme and at the
ubiquinone-binding site (Q site) in E. coli succinate dehydrogenase. Based on these
studies, we hypothesize that the mutation in succinate dehydrogenase enzyme of E.
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ictaluri may result in increased production of superoxide, which may cause oxidative
stress and DNA damage in the mutant strain Ei∆sdhC.
E. ictaluri is facultative anaerobic bacteria. Therefore, the TCA cycle is important
for them during aerobic respiration. We have previously constructed mutations in genes
encoding TCA cycle enzymes, and it is important to know whether there are growth
differences between these mutants and wild-type E. ictaluri. We expect that aerobic
growth will not be efficient in E. ictaluri TCA cycle mutants, but anaerobic growth
should be similar between TCA cycle mutants and wild-type E. ictaluri. Therefore, we
compared aerobic and anaerobic growth kinetics between wild-type strain 93-146 and
Ei∆sdhC, Ei∆frdA, Ei∆mdh, Ei∆sdhC∆frdA, and Ei∆mdh∆sdhC mutants.
The effect of sdhC deletion on endogenous superoxide production in E. ictaluri
was compared to wild-type E. ictaluri using ferricytochrome c reduction. To determine if
effects on superoxide production are specific to the sdhC subunit, superoxide production
was also compared to a sdhA deletion mutant (courtesy of Dr. Attila Karsi). Finally, the
effect of superoxide production on viability of TCA cycle mutants was determined by
comparing survivability of the sdh mutants on hydrogen peroxide (H2O2) relative to wildtype E. ictaluri both in the presence and in the absence of superoxide dismutase (SOD).
Material and methods
Growth kinetics
Ei∆sdhC, Ei∆frdA, Ei∆mdh, Ei∆frdA ∆sdhC, and Ei∆mdh∆sdhC mutants and
wild-type E. ictaluri were grown in triplicate in brain heart infusion (BHI) broth at 30°C.
Aerobic condition was obtained by growing the cultures at 30°C with rotary shaking. All
anaerobic growth assays were conducted using sealed vials containing medium. Vials
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were acclimated to anaerobic conditions in an anaerobic chamber and were kept at 30°C
throughout the experiment. Bacterial growth was measured at 6 h, 8 h, 12 h, 18 h, 24 h,
36 h, and 48 h post-inoculation using a spectrophotometer at OD600.
Detection and measurement of extracellular superoxide
For the detection and measurement of extracellular superoxide production, we
followed the protocols developed by Huycke et al. (1996) and modified by Korshunov
and Imlay (2006). All the reagents used in this study were brought from Sigma-Aldrich
(St. Louis, MO).
The production of extracellular superoxide was determined in wild-type E.
ictaluri and Ei∆sdhC, Ei∆sdhA, and Ei∆frdA∆sdhC mutants by measuring the ability of
superoxide to reduce ferricytochrome c. Each treatment included three replicates. To
measure the total extracellular superoxide, bacteria from exponential-phase (optical
density at 600 nm (OD600) of 0.6) were centrifuged, washed with PBS, and resuspended
to an OD600 of 0.2 in two 50-ml flasks, each containing 10 ml of pre-warmed PBS
supplemented with 0.2% glucose and 20 μM cytochrome c. Superoxide dismutase (SOD)
(30 U/ml) was added to one of the two flasks, and they were incubated at 30°C in a
shaking water bath. At 20, 40, and 60 min, 1.5 ml of cell suspension was withdrawn from
each flask and filtered using syringe filters. The filtrates were kept on ice, and the amount
of reduced cytochrome c was determined using the absorbance at 550 nm. Then 0.2 μM
potassium ferricyanide was added to the filtrates to oxidize cytochrome c, and then the
spectra were recorded again. The amount of reduced cytochrome c was calculated using
the ferricyanide-induced absorbance change at 550 nm. The fraction of cytochrome c
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reduction mediated by superoxide was then determined by comparing the degrees of
reduction in the paired samples with and without SOD.
To quantify superoxide formation by excreted metabolites, cell suspensions were
incubated without the addition of cytochrome c. At time points 20, 40, and 60 min, cells
were removed by filtration, and cytochrome c was added to the filtrate. Each aliquot was
split, and SOD was added to one of each of the paired samples. The samples were
incubated at 30°C for 15 minutes, which is sufficient to essentially complete the
autoxidation of excreted metabolites. Similar to the methods for extracellular superoxide
quantification, the amount of reduced cytochrome c was then determined using the
absorbance at 550 nm. Then 0.2 μM potassium ferricyanide was added to the filtrates to
oxidize cytochrome c, and then the spectra were recorded again. The fraction of
cytochrome c reduction mediated by superoxide was then determined by subtracting the
absorbance values from the paired samples with and without SOD.
Enzyme assay
E. ictaluri membranes were isolated using the protocol developed by Maklashina
et al. (1998). Briefly, 500 ml broth cultures of Ei∆sdhC and Ei∆sdhA were grown until
OD600 reached 0.8. Bacteria were collected by centrifugation at 4,500 × g for 10 min,
then suspended with 100 ml of 100 mM PBS–5 mM EDTA (pH 7.6), centrifuged again
as described above, suspended in 40 ml of the same buffer, and then frozen at −70°C.
Unlysed bacteria were removed by centrifugation (15 min at 10,000 × g), and the
supernatant was centrifuged for 60 min at 100,000 × g to collect the membranes. The
membrane fraction was suspended in 30 ml of the same buffer, and both centrifugation
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steps were repeated. Membranes were suspended in 50 mM PBS–0.2 mM EDTA (pH
7.8) to approximately 15 mg of protein/ml and frozen at −70°C.
Succinate dehydrogenase enzyme activity was measured using the protocol
reported by Zhao et al. (2006). Briefly, succinate dehydrogenase activity was assessed by
measuring phenazine methosulfate (PMS) mediated reduction of 2,6
dichlorophenolindophenol (DCIP). Electron transfer was initiated by adding 10 mmol/L
succinate to the mixture containing three concentrations of membrane fraction (5 μg/ml,
10 μg/ml, and 15 μg/ml), 0.75 mmol/L PMS, 30 umol/L DCIP, and 1 mmol/L KCN in
0.1 mol/L phosphate buffer at pH 7.8 at room temperature. The reduction of DCIP was
monitored by measuring absorbance at 600 nm.
Viability assay
The viability assay was conducted to determine whether providing SOD can
protect the viability of the TCA cycle mutants in the presence of H2O2. Wild-type and
mutants were grown to mid-log phase (OD600 0.8-1), pelleted by centrifugation for 10
min at 4200 rpm, and resuspended in 50 ml PBS (0.2 OD600). After resuspension, wildtype and mutants were split into 4 treatments groups: PBS control, PBS saline with 30%
hydrogen peroxide (final concentration 10mM ), saline with SOD (final concentration
30U/ml ), and saline with both hydrogen peroxide and SOD. Viable cells at 60 min (in
triplicate) were determined by serial dilution and plate counts.
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Results
Growth kinetics
Growth kinetics analysis revealed that there was no difference in the growth of
TCA cycle mutants and wild-type E. ictaluri during aerobic as well as anaerobic growth
conditions. One exception was the Ei∆frdA mutant, which grew slower than the other
strains (Figure 5.1). During aerobic growth of Ei∆sdhC, Ei∆frdA, Ei∆mdh,
Ei∆sdhC∆frdA, Ei∆mdh∆sdhC, and wild-type E. ictaluri, log phase occurred from 6 h to
approximately 12 h post-inoculation, and stationary phase occurred from approximately
12 h to 48 h (Fig. 5.1A). However, in anaerobic growth of the mutants and wild-type E.
ictaluri, cell growth was in lag phase from 6 h to approximately 12 h post-inoculation, in
log phase from 12 h to 18 h, and in stationary phase from approximately 18 h to 48 h
(Fig. 5.1B).
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Figure 5.1

Aerobic and anaerobic growth kinetics in wild-type strain 93-146 and
Ei∆sdhC, Ei∆frdA, Ei∆mdh, Ei∆frdA ∆sdhC, Ei∆mdh∆sdhC mutants.

(A) Aerobic growth curve for Ei∆sdhC, Ei∆frdA, Ei∆mdh, Ei∆frdA ∆sdhC,
Ei∆mdh∆sdhC, and wild-type E. ictaluri. (B) Anaerobic growth curve for Ei∆sdhC,
Ei∆frdA, Ei∆mdh, Ei∆frdA∆sdhC, Ei∆mdh∆sdhC, and wild-type E. ictaluri.
Determination and measurement of extracellular superoxide
To determine extracellular superoxide production, mutants Ei∆sdhC, Ei∆sdhA,
Ei∆frdA ∆sdhC, and wild-type E. ictaluri were assayed for superoxide production using
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reduction of ferricytochrome c in the absence and the presence of SOD. Results of
spectrophotometric assays representing average absorbance recorded from the three
replicates are shown in Figure 5.2A. The difference in reduction of ferricytochrome c in
the absence and presence of SOD represents the actual contribution of superoxide to the
measured reductive activity and is shown in Figure 5.2B. A low level of superoxide
production was detected by wild-type E. ictaluri 20 min after the addition of SOD, but
superoxide production was negligible at 40 min and 60 min. The same trend was present
in EiΔsdhC, except superoxide production was lower than wild-type E. ictaluri. No
superoxide production was detected for EiΔsdhA and EiΔfrdAΔsdhC (data not shown).
Therefore, elimination of succinate dehydrogenase genes did not cause increased
superoxide production in E. ictaluri.
No superoxide production was detected from E. ictaluri extracellular metabolites
(data not shown). Therefore, the superoxide production shown in Figure 5.2 is the result
of periplasmic superoxide production in E. ictaluri.
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Figure 5.2

Reduction of ferricytochrome c by Ei∆sdhC and wild-type E. ictaluri with
and without superoxide dismutase (SOD).

Each point represents the ferricyanide-induced absorbance change at 550 nm. (A) Time
points are measured from the addition of superoxide dismutase. (B) The calculated
release of superoxide. For each treatment, three replicates were included; data represents
the average absorbance of the replicates.
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Enzyme assay
We examined the effects of deletion mutations, Ei∆sdhC and Ei∆sdhA, on
succinate dehydrogenase activity by PMS-mediated reduction of DCIP. Figure 5.3 shows
the mean decrease in absorbance a 600 nm resulting from DCIP reduction, which reflects
succinate dehydrogenase activity. There was no change in succinate dehydrogenase
activity of mutant Ei∆sdhC when compared with wild-type E. ictaluri except at the
lowest membrane concentration (5 µg/ml), where decreased activity was detected. By
contrast, EiΔsdhA had decreased succinate dehydrogenase activity relative to wild-type E.
ictaluri at all membrane concentrations (5, 10, and 15 μg/ml) (Fig. 5.3).

Figure 5.3

Reduction of DCIP by wild-type E. ictaluri, Ei∆sdhC, and Ei∆sdhA at
different membrane fraction concentrations.

Each point represents the decrease in absorbance at 600 nm relative to the no membrane
control that resulted from DCIP reduction.
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Viability assay
A viability assay was conducted to determine whether providing SOD could
protect the viability of the Ei∆sdhC, Ei∆sdhA, Ei∆frdA, Ei∆sdhC∆frdA mutants when
challenged with hydrogen peroxide. Relative to the PBS control, viability of Ei∆sdhC,
Ei∆frdA, Ei∆sdhA∆frdA, and wild-type E. ictaluri decreased by 28% to 67% in the
presence of H2O2, whereas it increased slightly (6%) for Ei∆sdhA (Fig. 5.4). Similarly,
the bacterial viability for all mutants decreased by 10% to 75% in the presence of H2O2 +
SOD relative to the PBS control. However, the bacterial viability increased for Ei∆frdA
(43%) and wild-type E. ictaluri (133%) but decreased for Ei∆sdhA (13%), Ei∆sdhC
(18%), and Ei∆sdhA∆frdA (33%) in the presence of SOD only relative to the PBS
control.

Figure 5.4

Percent change in bacterial viability relative to phosphate buffer solution
(PBS) for Ei∆sdhC, Ei∆sdhA, Ei∆frdA, Ei∆frdA ∆sdhC, and wild-type E.
ictaluri (control).

Bacterial strains were incubated with phosphate buffer solution, 30 U/ml SOD, 15 mM
H2O2, or 30 U/ml SOD + 15 mM H2O2 for 1h at 25°C, and viable bacteria were
enumerated. The data presented are means from three replicates.
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Discussion
It has been shown that an E. ictaluri succinate dehydrogenase mutant is attenuated
and is susceptible to killing by catfish neutrophils (Karsi et al., 2009). We hypothesized
that the basis for this attenuation is increased superoxide production in the E. ictaluri
succinate dehydrogenase mutant. In the current chapter, we aimed to test this hypothesis.
It is also possible that E. ictaluri TCA cycle mutants are attenuated simply
because their growth rate is slower than wild-type E. ictaluri. Therefore, aerobic and
anaerobic growth kinetics was compared between wild-type strain 93-146 and Ei∆sdhC,
Ei∆frdA, Ei∆mdh, Ei∆sdhC∆frdA, Ei∆mdh∆sdhC mutants. We expected that aerobic
growth will not be efficient in E. ictaluri TCA cycle mutants, but anaerobic growth
should be similar to wild-type E. ictaluri. In contrast to our expectation, results showed
no difference between the growth of Ei∆sdhC, Ei∆mdh, Ei∆sdhC∆frdA, Ei∆mdh∆sdhC,
and wild-type E. ictaluri. However, the growth rate for Ei∆frdA was slower than wildtype E. ictaluri both aerobically and anaerobically. Similar results were reported by
(Steinsiek et al , 2011) in E. coli MG1655, which has mutations in frdA and sdhC genes.
They analyzed the frdA and sdhC mutants at different aerobiosis levels and found their
growth rate and cell yield were very similar to the parent strain. In E. coli, fumarate
reductase is proficient in succinate oxidation and is able to functionally replace succinate
dehydrogenase in aerobic respiration when this function has been disrupted (Guest et al,
1981). Thus, in E. ictaluri it is likely that fumarate reductase can replace succinate
dehydrogenase in the TCA cycle, which might be the reason why we found no difference
between the growth of Ei∆sdhC and wild-type E. ictaluri.
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E. ictaluri may also have a protein that can functionally replace malate
dehydrogenase. In E. coli, growth of a double mutant containing mdh and mqo deletions
is slower than growth of a mdh mutant (van der Rest et al. 2000). This indicated
malate:quinoneoxidoreductase (MQO) is capable of partly taking over the function of
malate dehydrogenase in a mdh mutant. It is possible that the TCA cycle enzymes work
in a similar manner in E. ictaluri (MQO replacing Mdh function), which might explain
the similar growth between Ei∆mdh and wild-type E. ictaluri.
To test the hypothesis that an E. ictaluri succinate dehydrogenase mutant has
increased superoxide production, the effect of sdhC deletion on endogenous superoxide
production in E. ictaluri was compared to wild-type E. ictaluri. To determine if effects on
superoxide production are specific to the sdhC subunit, superoxide production was also
compared to a sdhA deletion mutant. Results indicated low production of superoxide in
wild-type E. ictaluri and Ei∆sdhC. Ei∆sdhA and EiΔfrdAΔsdhC mutants had no
detectable superoxide production. In E. coli, site-directed mutations SdhD-H71L and
SdhC-H91L around the heme binding site resulted in enhanced superoxide production
(Zhao et al, 2006). Similarly, Slane et al, (2006) suggested that mutations in the genes
encoding succinate dehydrogenase caused increased superoxide production, metabolic
oxidative stress, and genomic instability in hamster fibroblasts. Our current study did not
show superoxide production in E. ictaluri. One of the reasons for this difference may be
that succinate dehydrogenase mutants in other studies (Zhao et al. 2006; Slane et al.
2006) had site directed mutations changing a single amino acid, while we deleted the
entire gene. Some bacterial species like E. coli and Enterococcus faecalis produce
superoxide without any mutations in succinate dehydrogenase (Korshunov and Imlay,
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2006; Huycke et al, 1996). However, other bacterial species do not produce superoxide,
including many gram-negative species (Huycke et al. 1996). Thus, our findings are not
surprising. Since the succinate dehydrogenase mutant of E. ictaluri did not have
increased production of superoxide, we conclude that the basis for attenuation of mutant
strain Ei∆sdhC is not due to the deleterious effect of superoxide.
Next, we determined whether the deletion mutations Ei∆sdhC and Ei∆sdhA had
decreased succinate dehydrogenase activity as determined by PMS-mediated reduction of
DCIP. Our results showed decreased succinate dehydrogenase activity of the mutant
Ei∆sdhA compared to Ei∆sdhC and wild-type E. ictaluri. SdhC serves as a membrane
anchor for succinate dehydrogenase, while SdhA contains a catalytic site for the enzyme.
Thus, the SdhC mutant may retain succinate dehydrogenase activity, while the SdhA
mutant does not.
Next, the effects of superoxide production on E. ictaluri viability were determined
by comparing the effects of sdhC, sdhA, frdA, and sdhC-frdA mutations on bacterial
viability both in presence and absence of hydrogen peroxide and SOD. Hydrogen
peroxide caused decreased viability of wild-type E. ictaluri and all the mutants except
Ei∆sdhA. Addition of SOD increased viability in Ei∆frdA and wild-type E. ictaluri in the
presence of hydrogen peroxide. However, SOD did not increase the viability of Ei∆sdhC,
Ei∆sdhA, or Ei∆frdA∆sdhC in the presence of hydrogen peroxide. Therefore, the
deleterious effect of superoxide production might be minimized by using SOD in Ei∆frdA
and wild-type E. ictaluri, but not in Ei∆sdhC, Ei∆sdhA, or Ei∆sdhC∆frdA.
In conclusion, results from the current study did not confirm our hypothesis that
increased superoxide production contributes to the attenuation of E. ictaluri succinate
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dehydrogenase mutants. Attenuation could not be explained by differences in growth rate
either. Further work remains to be done to determine the basis for attenuation of E.
ictaluri succinate dehydrogenase mutants.

97

References
Guest, J.R. 1981. Partial replacement of succinate dehydrogenase function by phage- and
plasmid-specified fumarate reductase in Escherichia coli. Journal of General
Microbiology 122, 171-179.
Hajjawi, O.S. 2011. Succinate dehydrogenase: Assembly, regulation and role in human
disease. European Journal of Scientific Research 51, 133-142.
Huycke, M.M., Joyce W., and Wack. M.F. 1996. Augmented production of extracellular
superoxide by blood isolates of Enterococcus faecalis. Journal of Infectious
Disease 173, 743-746.
Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P.S., and Ishii, N. 2005. A
mutation in the SDHC gene of complex II increases oxidative stress, resulting in
apoptosis and tumorigenesis. Cancer Research 65, 203-209.
Karsi, A., Gulsoy, N., Corb, E., Dumpala, P.R., and Lawrence, M.L. 2009. A highthroughput bioluminescence mutant screening strategy for identification of
bacterial virulence genes. Applied Environmental Microbiology 75 (7), 21662175.
Korshunov, S., and Imlay, J.A. 2006. Detection and quantification of superoxide formed
within the periplasm of Escherichia coli. Journal of Bacteriology 188, 6326-6334.
Lu, J. 2013. Identification of virulence factors in Edwardsiella ictaluri. Ph.D.
Dissertation, Mississippi State University, Department of Basic Sciences,
Mississippi State, Mississippi.
Maklashina, E., Berthold, D.A., and Cecchini, G. 1998. Anaerobic expression of
Escherichia coli succinate dehydrogenase: functional replacement of fumarate
reductase in the respiratory chain during anaerobic growth. Journal of
Bacteriology 180, 5989-5996.
Ohnishi, T., King, T.E., Salerno, J.C., Blum, H., Bowyer, J.R., and Maida, T. 1981.
Thermodynamic and electron paramagnetic resonance characterization of flavin in
succinate dehydrogenase. The Journal of Biological Chemistry 256, 5577-5582.
Page, C.C., Moser, C.C., Chen, X., and Dutton, P.L. 1999. Natural engineering principles
of electron tunnelling in biological oxidation-reduction. Nature (London) 402, 4752.
Slane, G.B., Burns, A.N., Smith, J.B., Kalen, L.A., and Goswami, C.P. 2006. Mutation of
succinate dehydrogenase subunit C results in increased O2-, oxidative stress, and
gemonic instability. Cancer Research 66, 7615-7624.

98

Steinsiek, S., Frixel, S., Stagge. S., SUMO, B.K. 2011. Characterization of E. coli
MG1655 and frdA and sdhC mutants at various aerobiosis levels. Journal of
Biotechnology. 154(1), 35-45.
van der Rest, M.E., Frank, C., and Molenaar, D. 2002. Functions of the membraneassociated and cytoplasmic malate dehydrogenases in the citric acid cycle of
Escherichia coli. Journal of Bacteriology. 182 (24), 6892-6899.
Zhao, Z., Rothery, A.R., Weiner, H.J. 2006. Effects of site-directed mutation in
Escherichia coli succinate dehydrogenase on the enzyme activity and production
of superoxide radicals. Biochemistry and Cell Biology 84, 1013-1021.

99

CHAPTER VI
CONCLUSIONS

The overall goal of this research was to develop a safe and efficacious live
attenuated vaccine for channel catfish against enteric septicemia of catfish (ESC). Results
shown in chapter II and III showed that we were able to construct nine live attenuated
vaccine candidates using in-frame deletion mutagenesis. Among these nine live
attenuated vaccines, three had mutations in genes encoding TCA cycle enzymes (sdhC,
mdh, and frdA) , two had mutation in C-1 protein metabolism enzymes (gcvP and glyA),
and other four were combinations between these two pathways (sdhC-mdh, sdhC-frdA,
sdhC-gcvP, and gcvP-glyA). Virulence of the constructed mutants was tested in juvenile
channel catfish using bioluminescence. This technique allowed us to detect bacterial
dissemination in vivo, and it allowed us to quantify the degree of attenuation of the
constructed mutants in catfish fingerlings.
After determining the degree of attenuation of the constructed mutants (chapters
II and III), they were tested for vaccine efficacy by immersion in channel catfish
fingerlings and fry (15-d old) (Chapter IV). The ability of the mutants to invade and
persist in catfish fingerlings was also determined. All the mutants provided
100%protection against E. ictaluri 93-146 infection in fingerlings except for the mutants
in C-1 metabolism (glyAgcvP and glyA), which provided lower protection (94.75%, and
87.98%, respectively). However, in catfish fry mortalities were reported for all mutants
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except for EiΔgcvPΔsdhC, which provided 99% protection against E. ictaluri infection.
The mutant strains EiΔsdhC, EiΔfrdA, EiΔfrdAΔsdhC, and EiΔsdhCΔgcvP were able to
invade catfish fingerlings and persist in the trunk kidney for at least 17 d post-infection.
Moreover, tissue concentrations in EiΔgcvPΔsdhCwere as high as wild-type until 7 d
post-infection. These results suggested good potential of EiΔgcvPΔsdhC mutant in
protecting catfish fry against ESC.
In our last study (Chapter V), the basis for attenuation of E. ictaluri succinate
dehydrogenase mutants was investigated. Aerobic and anaerobic growth kinetics
indicated that attenuation of E. ictaluri TCA cycle mutants was not due to a growth
defect. Furthermore, no increased production of superoxide was detected in E. ictaluri
sdhC or sdhA mutants. A succinate dehydrogenase enzyme assay showed that there was
little effect on enzyme activity due to sdhC deletion. However, a sdhA mutant did show
decreased succinate dehydrogenase activity. Wild-type E. ictaluri and all of the mutants
except EiΔsdhA had decreased viability in the presence of the hydrogen peroxide (H2O2),
but addition of SOD only increased viability of wild-type strain and EiΔfrdA.These
findings provided insight into the mechanism of attenuation of the E. ictaluri sdhC
mutant. It is important to note that this study evaluated superoxide production only in
aerobic conditions. An alternative future research strategy could be to examine
production of some known E. ictaluri virulence factors in wild-type strain and the sdhC
mutant grown aerobically and anaerobically using RT-PCR.
The overall results of this study provided us with valuable information on the
degree of attenuation as well as the safety of new E. ictaluri vaccine candidates. The
vaccine candidates showed good potential as live attenuated vaccines in catfish
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fingerlings. However, in catfish fry, only one vaccine candidate (EiΔgcvPΔsdhC) showed
99%safety and efficacy. It should be noted that we tested vaccine efficacy in 15-day-old
catfish fry. It is possible that there is a limit to the effectiveness of vaccinating catfish fry
at this age. Testing the vaccine candidates for efficacy in three-week old catfish fry might
show improved efficacy; vaccination of older fry can generate protection that lasts up to
six months (Mackey, 2002). However, this would require changing current production
practices. In the current study, vaccine candidates were only tested in controlled
laboratory conditions. Another potential future direction would be to test these vaccines
candidates in field conditions for possible commercialization.
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